Advanced search
Publication Cover
Journal of Microencapsulation
Micro and Nano Carriers
Volume 11, 1994 - Issue 1
Submit an article Journal homepage
6
Views
0
CrossRef citations to date
0
Altmetric
Literature Alerts

Literature Alerts

Pages 103-123 | Published online: 27 Sep 2008

LITERATURE ALERTS

  • Nonphospholipid liposomes in cosmetics. ABATE, K., Soap, Cosmet., Chem. Spec., 1993, 69, (5), 37–38. 40.
  • Future approaches to vaccine development: single-dose vaccines using controlled-release delivery systems. AGUADO, M. T., Vaccine, 1993, 11, (5), 596–597.
  • Antibody-targeted delivery of doxorubicin entrapped in sterically stabilized liposomes can eradicate lung cancer in mice. AHMAD, I., LONGENECKER, M., SAMUEL, J., and ALLEN, T. M., Cancer Res., 1993, 53, (7), 1484–1488.
  • Photosensitization of human bladder carcinoma cells in vitro by 9-acetoxy-tetra-n-propylporphycene (ATPPn) bound to liposomes from soya phosphatidylcholine. Aicher, A., Miller, K., Reich, E., and HAUTMAN, R., Opt. Eng. (Bellingham, Wash.), 1993, 32, (2), 342–346.
  • Delivery of lymph node-targeted adriamycin by gastric submucosal liposomal injection in rabbits. AKAMO, Y., YOTSUYANAGI, T., MIZUNO, I., IculNo, T., TANIMOTO, N., KURAHASHI, S., SAITO, T., YAMAMOTO, T., YASUI, T., ITABASHI, Y. et al., jpn. .7. Cancer Res., 1993, 84, (2), 208–213.
  • Reduced kallikrein excretion by liposome-encapsulated cyclosporin in the rat. AKBARIEH, M., ADAM., A., LEGRIS, F., and TAWASHI, R., y. Pharm. Pharmacol., 1993, 45, (2), 146–148.
  • Liposome delivery of antisense methylphosphonate and phosphorothioate oligonucleotides: a study with MLV, FATMLV and LUV liposomes. AKEITAR, S., and JULIANO, R. L., Proc. Int. Symp, Controlled Release Bioact. Mater., 19th, Controlled Release Soc., Deerfield, Ill, 1992, 345–346.
  • In vivo delivery of human alpha 1-antitrypsin gene to mouse hepatocytes by liposomes. Alino, S. F., Bobadilla, M., Garcia-SANz, M., LEJARRETA, M., UNDA, F., and HILLARIO, E., Biochem. Biophys. Res. Commun., 1993, 192, (1), 174–181.
  • Manipulation of large minichromosomes in Schizosaccharomyces pornbe with liposome-enhanced transformation. ALLSHIRE, R. C., Methods Enzymol., 1992, 216 (Recombinant DNA, Pt. G), 614–631.
  • Immune response to nasal delivery of antigenically intact tetanus toxoid associated with poly(t-lactic acid) microspheres in rats, rabbits and guinea pigs. ALMEIDA, A. J., ALPAR, H. O., and BROWN, M. R. w., y. Pharm. Pharmacol., 1993, 45, (3), 198–203.
  • Controlled release of tetranus toxoid from poly(lactic/glycolic acid) microspheres. ALONSO, M. J., COHEN, S., PARK, T. W., GUPTA, R. K., STEER, G. R., and LANCER, R., Proc. Int. Symp. Controlled Release Bioact. Mater., 19th, Controlled Release Soc., Deerfield, Ill, 1992, 122–123.
  • Liposomes as safe carriers of drugs and vaccines. ALVING, C. R., Liposome Dermatics. Griesbach Conf., Springer, Berlin, Germany, 1992, 226–232.
  • Lipid A and liposomes containing lipid A as adjuvants for vaccines. ALVING, C. R., Bact. Endotoxic Lipopolysaccharides, CRC, Boca Raton, Fla, 1992, 429–443.
  • Release characteristics stability of poly(1-lactide) microspheres and chemical stability of drugs in the microspheres. Aso, Y., YOSHIOKA, S., and TERAO, T., Proc. Int. Symp. Controlled Release Bioact. Mater., 19th, Controlled Release Soc., Deerfield, III, 1992, 310–311.
  • Stabilization of liposomes by freeze-thaw and lyophilization techniques. Difficulties and perspectives. AUSBORN, M., NUHN, P., and SCHREIER, H., Eur.J. Pharm. Biopharm., 1992, 38, (4), 133–136.
  • Contact-dependent, immune complex-mediated lysis of hapten-sensitized liposomes. Babbit, B., Burtis, L., Dentinger, P., Constantinides, P., Hillis, L., McGirl, B., and HUANG, L., Bioconjugate Chem., 1993, 4, (3), 199–205.
  • Influence of polyethylene glycol and cholesterol on liposome aggregation. BABINCOVA, M., and HIANIK, T., Acta Phys. Univ. Comenianae, 1992, 33, (1), 103–109.
  • Preparation of liposomes using a Mini-Lab 8.30H high-pressure homogenizer. BACHMANN, D., BRANDI., M., and GREGoRIADis, G., Int. y. Pharm., 1993, 91, (1), 69–74.
  • Liposomes as carriers of antimicrobial agents or immunodulatory agents in the treatment of infections. BARKER, W. I. A., LOKERSE, A. F., TEN-KATE, M. T., MELISSEN, P. M., VAN VIANEN, W., and VAN ETTEN, E. W Eur. y. Clin. Microbial. Infect. Dis., 1993, 12, Suppl. 1, S61–S67.
  • Liposomes with prolonged blood circulation and selective localization in Klebsiella pneumoniae-infected lung tissue. BAKKER, W. I. A., LOKERSE, A. F., TEN-KATE, M. T., MOUTON, J. W., WooDLE, M. C., and STORM, G., y. Infect. Dis., 1993, 168, (1), 164–171. 0265-2048/94 510.00 © 1994 Taylor & Francis Ltd.
  • Liposome production: historic aspects. BARENHOLZ, Y., Liposome Dermatics. Griesbach Conf., Springer, Berlin, Germany, 1992, 69–81.
  • Liposome-mediated transfection of intact viral particles reveals the plasma membrane penetration determines permissivity of tissue culture cells to rotavirus. BASS, D. M., BAYLOR, M. R., CHEN, C., MACKOW, E. M., BREMONT, M., and GREENBERG, H. B., J. Clin. Invest., 1992, 90, (6), 2313–2320.
  • Development of a single injection transmission-blocking malaria vaccine using biodegradable microspheres. BATHURST, I. C., BARR, P. J., KASLOW, D. C., LEWIS, D. H., ATKINS, T. J., and RICKEY, M. E., Proc. Int. Symp. Controlled Release Bioact. Mater., 19th, Controlled Release Soc., Deerfield, III, 1992, 120–121.
  • Preparation of acetaminophen microcapsules by coacervation-phase separation method. BAYKARA, T., and KARATAS, A., Drug Dev. Ind. Pharm., 1993, 19, (5), 587–601.
  • Effects of liposome encapsulated hemoglobin on the reticuloendothelial system. BEACH, M. C., MORLEY, J., SPIRYDA, L., and WEINSTOCK, S. B., Biomater., Artif. Cells, Immobilization Biotechnol., 1992, 20 (2-4), 771–776.
  • Influence of poly(butyl cyanoacrylate) nanoparticles and liposomes on the efficacy and toxicity of the anticancer drug mitoxantrone in murine tumor models. BECK, P., KREUTER, J., RESZKA, R., and FICHTNER, I., j. Microencapsulation, 1993, 10, (1), 101–114.
  • Liposome-incorporated dexamethasone palmitate: chemical and physical properties. BENAMEUR, H., DE GAND, G., BRASSEUR, R., VAN VOOREN, J. P., and LEGROS, F. J., Int. y. Pharm., 1993, 89, (3), 157–167.
  • Liposome-mediated macrophage depletion: an experimental approach to study the role of testicular macrophages in the rat. BERGH, A., DAMBER, J. E., and VAN ROOIJEN, N., .7. Endocrinol., 1993, 136, (3), 407–413.
  • Fifteen micrometer microspheres reflux up the pulmonary veins during pulmonary artery occlusion. BERNARD, S. L., OBERMILLER, T., POLISSAR, N. L., MENDENHALL, J. M., BUTLER, J., and LAKSHMINARAYAN, S., Microvasc. Res., 1993, 45, (3), 262–268.
  • Targeting of microdiscs in white cells to tibial abscesses in rabbits. BHAMRA, M., TYRRELL, M. R., HULME, A. L., DYE, J. F., and DUDLEY, H. A., y. Orthop. Res., 1993, 11, (3), 412–415.
  • A polymeric 'flippase' for surface-differentiated dipalmitoylphosphatidylcholine liposomes. BHATTACHARYA, S., MOSS, R. A., RINGSDORF, H., and SIMON, J.,Am. Chem. Soc., 1993,115, (9), 3812–3813.
  • Neutralization of intracellular tetanus toxin by liposome-entrapped antitoxin. BIGALKE, H., STUCKMANN, I., and BARTELS, F., Recent. Adv. Toxicol. Res., (World Conf. Anim., Plant Microb. Toxin), 10th, Natl. Univ. Singapore, Venom Toxin Res. Group, Singapore, Singapore, 1992, 355–360.
  • Magnetic microcapsules as novel biomonitors of cross-linking agents and diet-dependent reactive oxygen species in the human gastrointestinal tract. BINGHAM, S. A., SilAH, A. B., A., CummiNGs, J. H., and O'NE11,1„ I. K., Environ. Health Perspect., 1993, 99, 293–295.
  • Effect of degradable starch microspheres on the human mucociliary clearance. 1310ERK, E., HOLMBERG, K., BAKE, B., and EDMAN, P., Proc. Int. Symp. Controlled Release Bioact. Mater., 19th, Controlled Release Soc., Deerfield, III, 1992, 417–418.
  • Regulation of estrus, and ovulation in mares with progesterone or progesterone and estradiol biodegradable microspheres with or without PGF2alpha. BLANCHARD, T. L., VARNER, D. D., BURNS, P. J., EVERETT, K. A., BRINSKO, S. P., and BOEHNKE, L., Theriogenology, 1992, 38, (6), 1091–1106.
  • Liposome determatics to come according to the patent literature. BLECHER, P., Liposome Dermatics, Griesbach Conf., Springer, Berlin, Germany, 1992, 281–287.
  • Specific targeting with poly(ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times. BixmE, G., CEVC, G., CROMMELIN, M. D., BAKKER-WOUDENBERG, I. A., KLUFT, C., and STORM, G., Biochim. Biophys. Acta, 1993, 1149, (1), 180–184.
  • Development of a new assay for the determination of the hemolytic activity of drugs incorporated in emulsions and liposomes. BOCK, 'E. K., MUELLER, R. H., and MUELLER, B. W., Congr. Int. Technol. Pharm., 6th, Assoc. Pharm. Galenique Ind., Chatenay Malabry, Fr., 1992, 380–387.
  • Microencapsulation of drugs with aqueous colloidal polymer dispersions. BODMEIER, R., and WANG, J., 3, Pharm. Sci., 1993, 82, (2), 191–194.
  • Mobility and persistence of isazofos in granular and microencapsulated formulations in two soils, using field lysimeters. BOWMAN, B. T., Pestic. Sci., 1992, 36, (3), 181–188.
  • Stimulation of secretory antibodies against Bordetella pertussis antigens in the lungs of mice after oral or intranasal administration of liposome-incorporated cell-surface antigens. BROWNLIE, R. M., BRAHMRHATT, H. N., WHITE, D. C., FOUNTAIN, M. W., ROHDE, M., WEHI AND, J., and TIMMIS, K. N., Microb. Pathog., 1993, 14, (2), 149–160.
  • Protection of mice from fatal Toxoplasma gondii infection by immunization with p30 antigen in liposomes. B1:Low, R., and BOOTHROYD, J. C., 3. immunoi., 1991, 147, (10), 3496–3500.
  • Effects of Rothrops asper (Terciopelo) myotoxin III, a basic phospholipase A2, on liposomes and mouse gastrocnemius muscle. BULTRON, E., GUTIERREZ, J. M., and THELESTAM, M., Toxicon, 1993, 31, (2), 217–222.
  • Microencapsulation of metallic powders to prevent explosion and dust formation in their manufacture and processing. I. Morphology and kinetics of oxidation of microencapsulated powders. BURYKIN, A. A., NEIKOV, O. D., RABIN, P. B., and SHAROVA, L. S., Poroshk. Metall. (Kiev), 1991, (6), 98–103.
  • Evaluation of a passive microcapsule agglutination test for the screening of human leptospirosis. CACCIAPUOTI, B., CICERONI, L., ARIMITSU, Y., SATO, T., and SEKI, M., Eur. 3. Epidemiol., 1993, 9, (1), 92–96.
  • Targeted delivery of a heme oxygenase inhibitor with a lyophilized liposomal tin mesoporphyrin formulation. CANNON, J. B., MARTIN, C., DRUMMOND, G. S., and KAPPAS, A., Pharm. Res., 1993, 10, (5), 715–721.
  • Biodegradation of liquid and microencapsulated formulations of alachlor in a clay loam soil. CAPRI, E., and WALKER, A., Bull. Environ. Contam. Toxicol., 1993, 50, (4), 506–513.
  • Phospholipid adsorption onto polystyrene microspheres. CARMONA, R. A. M., and HERRINGTON, T. M., 1. Colloid Interface Sci., 1993, 156, (1), 19–23.
  • Topical treatment of acute hindlimb lymphedema of the rat using a troxerutin-phosphatidylcholine complex in liposomal-like microdispersion. CASLEY-SMITH, J. R., CASLEY-SMITH, J. R., CURB, S., and FOLD, M., Lymphology, 1993, 26, (1), 25–27.
  • Effect of the complexation of some nonsteroidal anti-inflammatory drugs with beta-cyclodextrin on the interaction with phosphatidylcholine liposomes. CASTELLI, F., PucList, G., GIAMMONA, G., and VENTURA, C. A., Int. 3. Pharm., 1992, 88, (1–3), 1–8.
  • Low velocity impact of electrically charged microspheres with planar surfaces under vacuum conditions. CAYLOR, M. J., DUNN, P. F., and BRACH, R. M., 3. Aerosol Sci., 1992, 23 (Suppl. 1), S19–S22.
  • Preparation and preliminary characterization of polylactide-based hemoglobin microspheres. CEDRATI, N., MAINCENT, P., THOMAS, F., LABRUDE, P., and VIGNERON, C., Congr. Int. Technol. Pharm., 6th, Assoc. Pharm. Galenique Ind., Chatenay Malabry, Fr., 1992, 252–261.
  • Encapsulation of the cobra cytotoxin P4 in liposomes. CHAIM, M. A., BORKOW, G., and OVADIA, M., Biotechnol. Appl. Biochem., 1993, 17, (1), 31–36.
  • Artificial liver support based on artificial cells with emphasis on encapsulated hepatocytes. CHANG, T. M. S., Artif. Organs, 1992, 16, (1), 71–74.
  • Antinociceptive activity of liposome-entrapped calcitonin by systemic administration in mice. CHEN, D., Li, Q. T., and LEE, K. H., Brain Res., 1993, 603, (1), 139–142.
  • Electroporation and commercial liposomes efficiently deliver soluble protein into the MHC class I presentation pathway. Priming in vitro and in vivo for class I-restricted recognition of soluble antigen. CHEN, W., CARBONE, F. R., and McCuisKEY, J., 3. Immunol. Methods, 1993, 160, (1), 49–57.
  • Hepatic carcinoma treated by hepatic arterial embolization using 1311 and chemotherapeutic agent gelatin microspheres: report of 9 cases. CHEN, X., Wu, Y., ZHONG, D., Li, L., TAN, T., XIE, X., YAN, C., and IA, X., Hua Hsi I Ko Ta Hsueh Hsueh Pao, 1992, 23, (4), 420–423.
  • Albumin microspheres as drug carrier for liver targeting. CHENG, Y. H., LIAO, G. T., Hou, S. X., Li, L., and ZHANG, M., Yaoxue Xuebao, 1993, 28, (1), 68–74.
  • Study on albumin microspheres as drug carrier for liver targeting. CHENG, Y. H., LIAO, G. T., Hou, S. X., Li, L., and ZHANG, M., Yao Hsueh Hsueh Pao, 1993, 28, (1), 68–74.
  • Polymer-coated liposomes for oral drug delivery. (I). Stability of polysaccharides-coated liposomes against bile salts. CHot, Y. W., and HAHN, Y. H., Yakche, Hakhoechi, 1992, 22, (3), 211–217.
  • Interactions of Laurdan with phosphatidylcholine liposomes: a high pressure FTIR study. CHONG, P. I., and WONG, P. T., Biochim. Biophys. Acta, 1993, 1149, (2), 260–266.
  • Synthesis and biodegradation characteristics of biodegradable monodisperse polymeric microspheres. CICEK, H., TUNCEL, A., and PISKIN, E., Kim. Kim. Muhendisligi Semp, 8th, Marmara Univ. Fac. Sci. Lett., Istanbul, Turk, 1992, 355–360.
  • A new method for the production of liposomes with high encapsulation potential. GITERNISI, U., SCIACCHITANE, 1VI., WILLIAMS, P., and ZANETTI, M., Cosmet Toiletries, Ed. Ital, 1992, 13, (5), 30–31.
  • Delivery of antisense oligonucleotides by poly(L-lysine) conjugation and liposome encapsulation. CLARENC, J. P., DEGLos, G., LEONETTI, J. P., MILHAUD, P., and LEBLEU, B., Anticancer Drug Des., 1993, 8, (1), 81–94.
  • Liposome encapsulated hemoglobin: long-term storage stability and in vivo characterization. CLIFF, R. O., LIGLER, F., GOINS, B., HOFFMANN, R. M., SPIELBERG, H., and RUDOLPH, A. S., Biomater, Art if. Cells, Immobilization Biotechnol, 1992, 20, (2-4), 619–626.
  • Interactions of complement fraction Clq, fibronectin, and immunoglobulin G with polyacrylic microparticles used as solid-phase in immunoassay. CLIQUET, F., CUILLIERE, M. L., MONTAGNE, P., and DUHEILLE, J., J. Biomed. Mater. Res., 1993, 27, (5), 587–597.
  • A comparative study of the anticancer efficacy of doxorubicin carrying microspheres and liposomes using a rat liver tumour model. CODDE, J. P., LUMSDEN, A. J., NAPOLI, S., BURTON, M. A., and GRAY, B. N., Anticancer Res., 1993, 13, (2), 539–543.
  • Microencapsulated PCM slurries for heat transfer and energy storage in spacecraft systems. COLVIN, D. P., MULLIGAN, J. C., BRYANT, Y. G., DUNCAN, J. L., and GRAVELY, B. T., Space Nucl. Power Syst., 1992, 11, 303–306.
  • Gene therapy for cystic fibrosis. COUTELLE, C., CAPLEN, N., HART, S., HUXLEY, C., and WILLIAMSON, R., Arch. Dis. Child, 1993, 68, (4), 437–440.
  • Initial clinical (phase I) trial of TLC D-99 (doxorubicin encapsulated in liposomes). Cowens, J. W., Creaven, P. J., Greco, W. R., Brenner, D. E., Tung, Y., Ostro, M., Pilkiewicz, F., Ginsberg, R., and PETRELLI, N., Cancer Res., 1993, 53, (12), 2796–2802.
  • Correlation between tumour drug disposition and the antitumour activity of doxorubicin-loaded microspheres: implications for the drugs' in vivo mechanism of action. CUMMINGS, J., WILLMOT'F, N., MARLEY, E. C., and SMYTH, J. F., Biochem. Pharmacol., 1993, 45, (12), 2550–2553.
  • Which is the most appropriate dosage of liposomal Amphotericin-B (Am Bisome) for the treatment of fungal infections in infants of very low birth weight? (letter). DA SILVA, L. P., AMARAL, J. M., and FERREIRA, N. C., Pediatrics, 1993, 91, (6), 1217–1218.
  • Chemoimmunotherapy of murine liver metastases with 5-fluorouracil in combination with liposome-encapsulated muramyl dipeptide. DAEMEN, T., DoNTJE, B. H. J., REGTS, J., and SCHERPHOF, G. L., J. Immunother., 1993, 13, (1), 31–35.
  • New radiopharmaceuticals for detecting infection. DATZ, F. L., and MoRToN, K. A., Invest. Radiol., 1993, 28, (4), 356–365.
  • Microencapsulated chlorpyrifos distribution in loamy sand and silty clay loam soils when applied with a sub-slab injector for subterranean termite control. DAVIS, R. W., KAmBLE, S. T., and ToLLEY, M. P., Bull. Environ. Contam. Toxicol., 1993, 50, (3), 458–465.
  • Capsaicin and its protective effect against UV-induced lipid peroxidation on liposomal preparations. DE, A. K., and GEmsH, J. J., Dev. Oncol., 1993, 71 (Eicosanoids Other Bioact. Lipids Cancer, Inflammation Radiat. Inj.), 377–380.
  • Ultrasound scattering properties of Albunex microspheres. DE JONG, N., and Horr, L., Ultrasonics, 1993, 31, (3), 175–181.
  • Solubilization of unilamellar liposomes by amphoteric alkyl betaine surfactants. DE LA MAZA, A., and PARRA, J. L., Colloids Surf., A, 1993, 70, (2), 189–197.
  • Liposomes in wool dyeing-the stability of dye-liposome systems and their application to untreated wool fibers. DE LA MAZA, A., PARRA, J. L., MANICH, A., and CODERCH, L., J. Soc. Dyers Colour, 1992, 108, (12), 540–545.
  • Obstacles in the application of microencapsulation in islet transplantation. DE VOS, P., WOLTERS, G. H., PRITSCHY, W. M., and VAN SCHILFGAARDE, R., Int. J. Artif. Organs, 1993, 16, (4), 205–212.
  • Antilisterial activity of pediocin AcH in model food systems in the presence of an emulsifier or encapsulated within liposomes. DEGNAN, A. J., BUYONG, N., and LUCHANSKY, J. B., Int. J. Food Microbiol., 1993, 18, (2), 127–138.
  • Disposition of liposomal gentamicin following intrabronchial administration in rabbits. DEMAEYER, P., AKODAD, E. M., GRAYET, E., SCHIETECAT, P., and VAN VOOREN, J. P., DROWART, A., YERNAULT, J. C., and LEGROS, F. J., y. Itlicroencapsulation, 1993, 10, (1), 77–88.
  • The human placental transferrin receptor: reconstitution into liposomes and electron microscopy. DEMANT, E. J. F., CHRISTIANSEN, K., and TRANUM, J. J., Biosci. Rep., 1992, 12, (6), 471–482.
  • Experimental use of liposomes carrying an antimetabolite (mitoxantrone) in filtering surgery. DENIS, P., TILI,EUL, P., BAUDRIMONT, M., KAPLAN, A., ROSTENE, W., and SARAUX, H., J. Fr. Ophtalmol., 1993, 16, (1), 14–20.
  • Nonspecific adsorption and covalent coupling of heparin on polyacrylate based microbeads. DENIZLI, A., KIREMITCCI, M., and PICKIN, E., Biomater. Artif. Cells Immobilization Biotechnol., 1993, 21, (2), 183–198.
  • Preparation of biodegradable and monodisperse poly(lactic acid) microspheres for using in controlled drug release systems. DENKBAS, E. B., TUNCEL, S. A., and PISKIN, E., Kim. Kim. Muhendisligi Semp., 8th, Marmara Univ. Fac. Sci. Lett., Istanbul, Turk, 1992, 349–354.
  • Liposome-encapculated hemoglobin using film hydration processing to form artificial red blood cells. DESHPANDE, S. V., and BEISSINGER, R. L., Biomater. Artif. Cells Immobilization Biotechnol., 1993, 21, (2), 135–151.
  • The effect of liposomal cefoperazone against Pseudomonas aeruginosa in a granulocytopenic mouse model of acute lung infection. Di Rocco, P. H., NACUCCHIO, M. C., SORDELLI, D. O., MANCUSO, F., and HOOKE, A. M., Infection (Munich), 1992, 20, (6), 360–364.
  • Liposomally-entrapped ganciclovir for the treatment of cytomegalovirus retinitis in AIDS patients. Experimental toxicity and pharmacokinetics, and clinical trial. DiAz-Li.opts, M., MARTOS, M. J., ESPANA, E., CERVERA, M., VII,A, A. O., NAVEA, A., MOLINA, F. J., and ROMERO, F. J., Doc. Ophthalmol., 1992, 82, (4), 297–305.
  • Microviscosity measurements for the optimization of liposome and emulsion formulations. DIEDERICHS, J. E., MEHNERT, W., LucRs, J., S., and MUELLER, R. H., Congr. Int. Technol. Pharm., 6th, Assoc. Pharm. Galenique Ind., Chatenay Malabry, Fr., 1992, 138–147.
  • A comparison of drug release from thermoresponsive microspheres and disks. DINARVAND, R., and D'EMANUELE, A., Proc. Int. Symp. Controlled Release Bioact. Mater., 19th, Controlled Release Soc., Deerfield, Ill, 1992, 373–274.
  • Modification of reticuloendothelial function by liposome-encapsulated muramyl dipeptide in jaundiced rats treated with biliary decompression. DING, J. W., ANDERSSON, R., 1-1121,TBERG, B., SOLTESZ, V., and BENGMARK, S., Scand. J. Gastroenterol., 1993, 28, (1), 53–62.
  • Influence of total surface area of core material on yield of deposited coacervate. DITTRICH, M., MELICHAR, L., and SMETANOVA, V., J. microencapsuiation, 1993, 10, (1), 45–54.
  • Incorporation of N-acylethanolamine phospholipids into egg phosphatidylcholine vesicles: characterization and permeability properties of the binary systems. DOMINGO, J. C., MORA, M., and AFRICA-DE-MADARIAGA, M., Biochim. Biophys. Acta, 1993, 1148, (2), 308–316.
  • Preparation, properties and biological function of liposome-encapsulated hemoglobin. Domoxos, G., JoRsxt, B., and SCHMIDT, K. H., Biomater. Artif. Cells, Immobilization Biotechnol., 1992, 20, (2-4), 345–354.
  • Partition of sodium dodecyl sulfate into stratum corneum lipid liposomes. DOWNING, D. T., ABRAIIAM, W., WEGNER, B. K., WILLMAN, K. W., and MARSEIALL, J. L., Arch. Dermatol. Res., 1993, 285, (3), 151–157.
  • Halide permeation through three types of epithelial anion channels after reconstitution into giant liposomes. DUSZYK, M., Litt, D., FRENCIE, A. S., and MAN, S. F., Eur. Biophys. y., 1993, 22, (1), 5–11.
  • Fusion of immunodeficiency viruses with liposomes and cells: inhibition of human immunodeficiency virus type 1 infectivitiy by cardiolipin liposomes. DUZGUNES, N., LARSEN, C. E., STAMATATOS, L., and KONOPKA, K., Adv. Membr. Fluid, 1992, 6 (Membr. Interact. HIV), 317–327.
  • Fusion of influenza, Sendai and simian immunodeficiency viruses with cell membranes and liposomes. DUZGUNES, N., PEDRoso-DE-LIMA, M. C., LARSEN, C. E., STAMATATOS, U., FLASHER, D., ALFORD, D. R., FRIEND, D. S., and NIR, S., Cell Model Membr. Interact. (Proc. Symp.), Plenum, New York, N.Y., 1991, 179–197.
  • Cationic liposome-mediated RNA transfection. DWARKI, V. J., MALONE, R. W., and VERMA, I. M., Methods Enzymol., 1993, 217, 644–654.
  • Immunization of rabbits with enterotoxigenic E. coli colonization factor antigen (CFA/I) encapsulated in biodegradable microspheres of poly(lactide-co-glycolide). EDELMAN, R., RUSSELL, R. G., LosoNsxy, G., TALL, B. D., TACKET, C. O., LEVINE, M. M., and LEwis, D. H., Vaccine, 1993, 11, (2), 155–158.
  • Topical delivery of liposomally encapsulated ingredients evaluated by in vitro diffusion studies. EGBARIA, K., and WEINER, N., Liposome Derrnatics, Criesbach Conf., Springer, Berlin, Germany, 1992, 172–181.
  • Spectroscopic properties of the potentiometric probe merocyanine-540 in solutions and in liposomes. EHRENBERG, B., and PEVZNER, E., Photochem. Photobiol., 1993, 57, (2), 228–234.
  • Chromatographic analysis and pharmacokinetics of liposome-encapsulated doxorubicin in non-small-cell lung cancer patients. EMBREE, L., GELmo.N, K. A., LOHR, A., MAYER, L. D., CoLDNIAN, A. J., Cut,Eis, P. R., PALAITIS, W., PII,KIEWICZ, F., HUDON, N. J. et al., J. Pharm. Sci., 1993, 82, (6), 627–634.
  • 99 mTc 4abelled monodisperse latex particles coated with amino or carboxyl groups for studies of G1 functions. ERCAM, M. T., TuNcEt., S. A., CANER, B. E., and PESKIN, E., J. Microencapsulation, 1993, 10, (1), 67–76).
  • A case of chronic progressive rhinocerebral mucormycosis treated with liposomal amphotericin B and surgery (letter). ERICSSON, M., ANNIKO, M., GusTAFssoN, H., aHJALT, C. A., STENLING, R., and TARNVIK, A., Clin. Infect. Dis., 1993, 16, (4), 585–586.
  • Liposomes in the preparation of new pharmaceutical forms. FABBRI, L., and BIGIOLI, F., G. Med. Mil., 1992, 142, (3), 227–232.
  • Size-dependent response of liposomes to phospholipid transmembrane redistribution: from shape change to induced tension. FARCE, E., and DEVAUX, P. F., j. Phys. Chem., 1993, 97, (12), 2958–2961.
  • Differential aluminum lactate toxicity in rabbits using either aqueous solutions or liposomal suspensions. FAVARATO, M., and ZATTA, P. F., Toxicol. Lett., 1993, 66, (2), 133–146.
  • Acyl chain orientational order in large unilamellar vesicles: comparison with multilamellar liposomes: a 2H and 31P nuclear magnetic resonance study. FENSKE, D. B., and CuLus, P. R., Biophys. .7., 1993, 64, (5), 1482–1491.
  • Preparation of liposomes by use of a high-pressure pump. FEUILLADE, G., FERRANDON, O., MAZET, M., CHAMBON, S., and PICOT, J. P., Parfums, Cosmet., Aromes, 1992, 104, 85–90.
  • Therapy of murine spontaneous renal cancer metastases by coadministration of liposomes containing macrophage activators and cytokines. FIDLER, 1. J., DINNEY, O. P. N., and KILLION, J. J Hemopoietic Growth Factors Mononucl. Phagocytes, Symp., Karger, Basel, Switz, 1993, 148–156.
  • Microspheres of human serum albumin with barbiturates: effect of drug partition coefficient on preparation and drug release. FILIPOVIC, G. J., and JALSENJAK, I., J. Pharm. Pharmacol., 1993, 45, (5), 394–399.
  • Treatment of antigen-induced arthritis in rabbits with liposome-entrapped methotrexate injected intra-articularly. FOONG, W. C., and GREEN, K. L., J. Pharm. Pharmacol., 1993, 45, (3), 204–209.
  • Dependence of merocyanine 540 incorporation into lecithin liposomes on the presence of albumin. FRANKOVA, R., Acta Phys. Univ. Comenianae, 1992, 33, (1), 111–116.
  • Preparation and properties of liposomes containing vitamin E. FREISLEBEN, H. J., and Mentrup, E., Vitam. E Health Dis., Dekker, New York, N.Y., 1993, 193–206.
  • CDP-choline entrapment and release from multilamellar and reverse-phase evaporation liposomes. FRESTA, M., PUGLISI, G., PANIC°, A. M., DI MARcos, S., and MAZZONE, G., Drug Dev. Ind. Pharm., 1993, 19, (5), 559–585.
  • Evaluation and optimization of liposomes as a delivery device for methotrexate. FRESTA, M., PUGLISI, G., PIGNATELLO, R., and GIOVINAZZO, C., Pharmazie, 1992, 47, (12), 926–929.
  • Induction of immune response against a short synthetic peptide antigen coupled to small neutral liposomes containing monophosphoryl lipid A. FRIEDE, M., MULLER, S., BRIAND, J. P., VAN-REGENMORTEL, M. H., and SCHUBER, F., Mol. Immunol., 1993, 30, (6), 539–547.
  • Lyophilized liposomes as shelf items for the preparation of immunogenic liposome-peptide conjugates. FR1EDE, M., VAN-REGENMORTEL, M. H. V., and SCHUBER, F., Anal. Biochem., 1993, 211, (1), 117–122.
  • Polymethylmethacrylate particles enhance DNA and protein synthesis of human fibroblasts in vitro. FRONDOZA, C. G., TANNER, K. T., JONES, L. C., and HUNGERFORD, D. S., J. Biome& Mater. Res., 1993, 27, (5), 611–617.
  • Effect of ibuprofen on monocyte activation by liposome-encapsulated muramyl tripeptide phosphatidylethanolamine (CGP 19835A): can ibuprofen reduce fever and chills without compromising immune stimulation? FUJ1MAKI, W., GRIFfiN, J. R., and KLEINERMAN, E. S., Cancer Immunol. Immunother., 1993, 36, (1), 45–51.
  • Prolongation of the circulation time of doxorubicin encapsulated in liposomes containing a polyethylene glycol-derivatized phospholipid: pharmacokinetic studies in rodents and dogs. GABIZON, A. A., BARENHOLZ, Y., and BIALER, M., Pharm. Res., 1993, 10, (5), 703–708.
  • B cells do not present antigen covalently linked to microspheres. GAI,EI,LI, A., CHARLOT, B., DERIAUD, E., and LECLERC, C., Immunology, 1993, 79, (1), 69–76.
  • Interaction of surfactants with model and biological membranes. XI. Calorimetric study of the interaction of local anesthetics and beta-blockers (2-(alkyloxy)pheny1)-2-(1-piperidinyflethyl esters of carbamic acid, with dipalmitoylphosphatidylcholine liposomes. GAI,I.OVA, J., BAGELOVA, J., CIZMARIK, J., and BALGAVY, P., Pharmazie, 1992, 47, (11), 873–874.
  • Influence of various topical liposome preparations with and without active ingredients on the cutaneous blood flow. GEHRING, W., KLEIN, M., and GLOOR, M., Liposome Dermatics, Griesbach Conf., Springer, Berlin, Germany, 1992, 315–319.
  • Effect of blood-brain barrier and blood-tumor barrier modification on central nervous system liposomal uptake. GENNUSO, R., SPIGELMAN, M. K., CHINOL, M., ZAPPULLA, R. A., NIEVES, J., VALLABHAJOSULA, S., PACIUCCI, P. A., GOLDSNIrrit, S. J., and HOLLAND, J. F., Cancer Invest., 1993, 11, (2), 118–128.
  • Blue red cells: the association with liposomes and red cells of lacZ fusion polypeptides containing the membrane-anchoring sequence from cytochrome b5. GEORGE, S. K., XL', Y. H., and IHI,ER, G. M., New Technol. Concepts Reducing Drug Toxic., CRC, Boca Raton, Fla., 1993, 41–59.
  • Incorporation of amphotericin B (Fungizone) in rat brain total lipid liposomes markedly decreases its i.v. toxicity in mice. GF,RGEI„ D., and ONDRIAS, K., Pharmazie, 1993, 48, (3), 202–205.
  • Mode of formation and structural features of DNA-cationic liposome complexes used for transfection. GERSHON, H., GHIRLANDO, R., GUTTMAN, S. B., and MINSKY, A., Biochemistry, 1993, 32, (28), 7143–7151.
  • Hyaluronic acid derivatives microspheres as carrier for NGF: in vitro characterization. GHEZZO, E., BENEDETTI, L., FERRARI, G., BIVIANO, F., and CALLEGARO, L., Proc. Program Int. Symp. Controlled Release Bioact. Mater., 18th, Controlled Release Soc., Deerfield, III, 1991, 613–614.
  • A hydrolytic reporter of copper(II) availability in artificial liposomes. GHIRLANDA, G., SCRIMIN, P., TECILLA, P., and TONELLATO, U., Y. Org. Chem., 1993, 58, (11), 3025–3029.
  • Chemical composition of liposomes and its influence on the humidity of normal skin. GHYCZY, M., Liposome Dermatics, Griesbach Conf., Springer, Berlin, Germany, 1992, 308–314.
  • White beeswax microspheres: a comparative in vitro evaluation of cumulative release of the anticancer agents fluorouracil and ftorafur. GIANNOLA, L. I., DI-STEFANO, V., and DE-CARO, V., Pharmazie, 1993, 48, (2), 123–126.
  • Ultrasound contrast agents. GOLDBERG, B. B., Clin. Diagn. Ultrasound, 1993, 28, 35–45.
  • Electric potentiation, cooperativity, and synergism of magainin peptides in protein-free liposothes. GOMES, A. V., DE-WAAL, A., BERDEN, J. A., and WESTERHOFF, H. V., Biochemistry, 1993, 32, (20), 5365–5372.
  • Development and characterization of microspheres of human serum albumin as a new system for drug transport and release. GONZALEZ, R. J., MEDINA, P. M. M., CEREZO, G. A., and SANCHEZ, M. J., Farm. Hosp., 1992, 16, (4), 263–267.
  • Use of novel ädjuvants and delivery systems to improve the humoral and cellular immune response to malaria vaccine candidate antigens. GORDON, D. M., Vaccine, 1993, 11, (5), 591–593.
  • Nosocomial infection with microsphere beds (letter). GOULD, F. K., and FREEMAN, R., Lancet, 1993, Jul. 24, 342, (8865), 241–242.
  • Tight insertion of cytochrome b5 into large unilamellar vesicles. GREENHUT, S. F., TAYLOR, K. M., and ROSF,MAN, M. A., Biochim. Biophys. Acta, 1993, 1149, (1), 1–9.
  • An enzyme-linked antiglobulin test to quantify nanogram quantities of IgG on polystyrene microspheres. GREENWALT, T. J., DOMINO, M. M., and DUMASWALA, U. J., Vox Sang., 1992, 63, (4), 272–275.
  • Liposomes in drug delivery: structure, behavior in vivo and applications. GREGORIADIS, G., Appl. Cosmetol., 1992, 10, (3), 61–64.
  • Coupling of ligands to liposomes independently of solute entrapment: observations on the formed vesicles. GREGORIADIS, G., GARCON, N., DA-SILVA, H., and STERNBERG, B., Biochim. Biophys. Acta, 1993, 1147, (2), 185–193.
  • Liposomes in drug delivery: present and future. GREGORIADIS, G., Liposome Dermatics, Griesbach Conf., Springer, Berlin, Germany, 1992, 346–352.
  • Liposomes in drug delivery. Clinical, diagnostic and ophthalmic potential. GREGORIADIS, G., and FLORENCE, A. T., Drugs, 1993, 45, (1), 15–28.
  • Potentiation of antitumor immunotoxins by liposomal monensin. GRIFfiN, T., RYBAK, M. E., RECHT, L., SING1-1, M., SALIMI, A., and RASO, V., y. Natl. Cancer Inst., 1993, 85, (4), 292–298.
  • Rapid positive selection of CD34 + cells using magnetic microspheres coated with monoclonal antibody QBEND/10 linked via a cleavable disulphide bond. GRIMSLEY, P. G., Amos, T. A., GORDON, M. Y., and GREAvEs, M. F., Leukemia, 1993, 7, (6), 898–908.
  • The effect of surface charge on the hydrolysis kinetics of partially hydrogenated egg phosphatidylcholine and egg phosphatidylglycerol in aqueous liposome dispersions. GRIT, P. G., and CROMMELIN, D. J., Biochim. Biophys. Acta, 1993, 1167, (1), 49–55.
  • Hydrolysis of saturated soybean phosphatidylcholine in aqueous liposome dispersions. GRIT, M., UNDERBERG, W. J., and CROMMELIN, D. J., y. Pharm. Sci., 1993, 82, (4), 362–366.
  • The effect of surface charge on the hydrolysis kinetics of partially hydrogenated egg phosphatidylcholine and egg phosphatidylglycerol in aqueous liposome dispersions. GRIT, M., and CROMMELIN, D. J. A., Biochim. Biophys. Acta, 1993, 1167, (1), 49–55.
  • Hydrolysis of saturated soybean phosphatidylcholine in aqueous liposome dispersions. GRIT, M., UNDERBERG, W. J. M., and CROMMELIN, D. J. A., J. Pharm. Sci., 1993, 82, (4), 362–366.
  • Hydrolysis of partially saturated egg phosphatidylcholine in aqueous liposome dispersions and the effect of cholesterol incorporation on hydrolysis kinetics. GRIT, M., ZUIDAM, N. J., UNDERBERG, W. J. M., and CROMMELIN, D. J. A., y. Pharm. Pharmacol., 1993, 45, (6), 490–495.
  • Hydrolysis and stability of acetylsalicylic acid in stearylamine-containing liposomes. HABIB, M. J., and ROGERS, J. A., 7. Pharm. Pharmacol., 1993, 45, (6), 496–499.
  • Comparative activity of a liposomal and a conventional econazole preparation for topical use according to a guinea pig tinea model. HAENEI„ H., BRAUN, B., and JoYtc, N., Liposome Dermatics, Griesbach Conf., Springer, Berlin, Germany, 1992, 251–257.
  • Pharmacologic effects of cisplatin microspheres on peritoneal carcinomatosis in rodents. HAGIWARA, A., TAKAHASHI, T., KOJINIA, O., TAMAGUCHI, T., SASABE, T., LEE, M., SAKAKURA, C., SHOUBAYASHI, S., IKADA, Y., and HYON, S. H., Cancer (Philadelphia), 1993, 71, (3), 844–850.
  • Protection of islets of Langerhans from antibodies by microencapsulation with alginate-poly-l-lysine membranes. HALLE, J. P., BOURASSA, S., LEBLOND, F. A., CHEVALIER, S., BEAUDRY, M., CHAPDELAINE, A., COUSINEAU, S., SAINTONGE, J., and YALE, J. F., Transplantation, 1993, 6, 350–354.
  • Mechanical properties of vesicles. H. A model for osmotic swelling and lysis. HALLETT, F. R., MARSH, J., NICKEL, B. G., and Woof), J. M., Biophys. 7., 1993, 64, (2), 435–442.
  • Electrochemical studies of redox probes in membrane mimetic assemblies. Liposomes and cast lipid films. HAN, M., and KAIFER, A. E., Electrochem. Colloids Dispersions (Symp. Electrochem. Microheterog. Fluids), VCH, New York, N.Y., 1992, 105–117.
  • Kinetic modeling of liposome degradation in blood circulation. HARASHIMA, H., KumE, Y., YAMANE, C., and KIWADA, H., Biopharm. Drug Dispos., 1993, 14, (3), 265–270.
  • Distinction between the depletion of opsonins and the saturation of uptake in the dose-dependent hepatic uptake of liposomes. HARASHIMA, H., SAKATA, K., and KIWADA, H., Pharm. Res., 1993, 10, (4), 606–610.
  • Accumulation of doxorubicin and other lipophilic amines into large unilamellar vesicles in response to transmembrane pH gradients. HARRINGAN, P. R., WONG, K. F., REDELMEIER, T. E., WHEELER, J. J., and CuLus, P. R., Biochim. Biophys. Acta, 1993, 1149, (2), 329–338.
  • The influence of gamma irradiation on the release of melatonin from poly(lactide-co-glycolide) microspheres. HARTAS, S. R., COLLETT, J. H., and BOOTH, C., Proc. Int. Symp. Controlled Release Bioact. Mater., 19th, Controlled Release Soc., Deerfield, Ill, 1992, 321–322.
  • Basic approach to application of liposome for cancer chemotherapy. HASHIMOTO, Y., and SUZUKI, S., Tohoku y. Exp. Med., 1992, 168, (2), 361–369.
  • Liposomes or HDL and phospholipid transfer to adrenocortical cells in culture. HATHOUT, Y., MAumE, G., and MAUME, B. F., C. R. Seances Soc. Biol. Fil., 1992, 186, (4), 425–426.
  • In vitro release of mitomycin C and Adriamycin from temperature-sensitive liposomes. HAYAKAWA, E., HOSOKAWA, T., KATO, Y., and Pro, K., Proc. Int. Symp. Controlled Release Bioact. Mater., 19th, Controlled Release Soc., Deerfield, Ill, 1992, 365–366.
  • The preparation of albumin microspheres containing doxorubicin. HE, W., REN, J., Sc, M., ZHANG, Y., and GAO, L., Zhongguo Yaoxue Zazhi, 1992, 27, (11), 656–658.
  • Influence of liposome charge and composition on their interaction with human blood serum proteins. HERNANDEZ, C. T., VILLALAIN, J., and GOMEZ, F. J. C., Mol. Cell. Biochem., 1993, 120, (2), 119–126.
  • Permeability of liposomal membranes to molecules of environmental interest: results from NMR experiments employing shift agents. HERRING, F. G., CULLEN, W. R., NELSON, J. C., and PHILLIPS, P. S., Bull. Magn. Reson., 1992, 14, (1–4. Proc. Int. Soc. Magn, Reson. Meet., 11th, 1992), 289–292.
  • Biliary elimination of bromsulfthalein, phenolphthalein, and doxorubicin released from microspheres following intravenous administration. HICKEY, A. J., TIAN, Y., PARASRAMPURIA, D., and KANKE, M., Biopharm. Drug Dispos., 1993, 14, (2), 181–186.
  • Tumor-cytolytic activity and TNF secretion of the rat liver macrophage population after intravenous administration of liposome-encapsulated MDP. HOEDEMAKERS, R. N. M. J., DAEMEN, T., and SCHERPHOF, G. L., Cells Hepatic Sinusoid, 1991, 3, 319–323.
  • Tumoristatic activity of liposomes reconstituted from tumor associated antigens and interleukin 2 for immunotherapy of fibrosarcomas in BALB/c mice. HOFFMANN, J., BIMMLER, M., LASCH, J., and GIESEMANN, P.,]. Liposome Res., 1993, 3, (1), 107–121.
  • Comparative assessment of regional left atrial perfusion by laser Doppler and radionuclide microsphere techniques. HOIT, B. D., WALSH, R. A., SHAO, Y., GAI3EL, M., and MILLARD, R., Cardiovasc. Res., 1993, 27, (3), 508–514.
  • Kinetic control of protein folding by detergent micelles, liposomes, and chaperonins. HoRowiTz, P. M., ACS Symp. See., 1993, 526 (Protein Folding), 156–163.
  • Monodisperse microspheres of copolymers of glycidyl methacrylate and its derivatives as materials for biomedical application. HOSAKA, S., MCRAO, Y., TAMAKI, H., MASUKO, S., MIURA, K., and KAWABATA, Y., Polym, Int., 1993, 30, (4), 505–511.
  • A morphological study of the effects of liposomized albendazole on the muscle phase of Trichinella spiralis in mice. HRCKOVA, G., VELEBNY, S., and HORAK, J., y. Helminthol., 1993, 67, (1), 24–30.
  • Liposome encapsulation enhances the efficacy of adriamycin to inhibit tumor in vivo. Hu, L., ZHAI, Y., ZHENG, C., and DUNG, Z., Shengum Huaxue Zazhi, 1993, 9, (1), 76–80.
  • Extravasation and transcytosis of liposomes in Kaposi's sarcoma-like dermal lesions of transgenic mice bearing the HIV tat gene. HUANG, S. K., MARTIN, F. J., JAY, G., VOGEL, J., PAPAHADJOPOULOS, D., and FRIEND, D. S., Am. I. Pathol., 1993, 143, (1), 10–14.
  • A new in vivo assay of the reactions of microencapsulated human tumor cells to chemotherapeutic drugs. HWANG, J. M., CHEN, C. F., Hsu, W. L., and CHEN, K. Y., Chung Hua I Hsueh Tsa Chili (Taipei), 1993, 51, (3), 166–175.
  • Microencapsulation of Lactococcus lactis within cross-linked gelatin membranes. HYNDMAN, C. L., GROBOILLOT, A. F., PONCELET, D., CHAMPAGNE, C. P., and NEUF'ELD, R. J., 7. Chem. Technol. Biotechnol., 1993, 56, (3), 259–263.
  • Non-radioactive coloured microsphere measurement of regional tissue blood flow for axial pattern flaps in rabbits. 'NADA, Y., TAMAI, S., MIZUNIOTO, S., ONO, H., KAWANISlif, K., and FUKUI, A.,]. Plast. Surg., 1993, 46, (2), 127–131.
  • Preparation of lipid emulsions (lipid microspheres) and their characteristics as drug carrier. Is00, F., Zairyo Gijutsu, 1993, 11, (1), 11–15.
  • Morphology of core-shell type polymer microspheres on carbon substrates. Ismzu, K., 7. Colloid Interface Sri., 1993, 156, (2), 299–304.
  • Kinetics of spreading of DOPC liposomes at the air-water interface subjected to phospholipase A2 hydrolysis. IVANOVA, Tz., RANEVA, V., PANAIOTOV, I., and VERGER, R., Colloid Polym. Sri., 1993, 271, (3), 290–297.
  • Investigation of reconstitution of the Na, K-ATPase in lipid vesicles. IVASHCHUK-KIENBAUM, Yu A., RIEK, R., and APELL, H. J., Biochim. Biophys. Acta, 1993, 1148, (2), 321–330.
  • Evaluation of biodegradable cefazolin sodium microspheres for the prevention of infection in rabbits with experimental open tibial fractures stabilized with internal fixation. JACOB, E., CIERNY, G. 3D, FALLON, M. T., McNETI.I., J. F. JR, and SIDERYS, G. S.,]. Orthop. Res., 1993, 11, (3), 404–411.
  • Encapsulation by interfacial polycondensation. III. Microencapsulation; the influence of process conditions on wall permeability. JANSSEN, L. J. J. M., BOERSMA, A., and TE-NuENDuis, K.,]. Membr. Sri., 1993, 79, (1), 11–26.
  • The preparation and characterization of poly(lactide-co-glycolide) microparticles. II. The entrapment of a model protein using a (water-in-oil)-in-water emulsion solvent evaporation technique. JEFFERY, H., awls, S. S., and O'HAGAN, D. T., Pharm. Res., 1993, 10, (3), 362–368.
  • Selective binding and transcytosis of latex microspheres by rabbit intestinal M cells. JEPSON, M. A., SIMMONS, N. L., SAVIDGE, T. C., JAMES, P. S., and HIRST, B. H., Cell Tissue Res., 1993, 271, (3), 399–405.
  • Targeting and delivery of bactericide to adsorbed oral bacteria by use of proteoliposomes. JONES, M. N., FRANCIS, S. E., HUTCHINSON, F. J., HANDLEY, P. S., and LYLE, I. G., Biochim. Biophys. Acta, 1993, 1147, (2), 251–261.
  • Treatment of gamma radiation-induced transplanted leukemia in ICRC mice by liposomally encapsulated 5-fluoro uracil. JosHi, S. V., VAIDYA, S. G., NERuRKAR, V. R., and SOMAN, C., Leuk. Res., 1993, 17, (7), 601–607.
  • Fragrance-loaded lyophilized liposomes. JUSZYNSKI, M., AZOURY, R., and RAFAELOFF, R., Seifen, Ode, Fette, Wachse, 1992, 118, (14), 811–812. 814–815.
  • Preparation of inorganic material composite polymer microspheres by suspension polymerization. KANIIYAMA, M., and KOYAMA, K., Kobunshi Ronbunshu, 1993, 50, (4), 227–233.
  • Excited state reactions of amphiphilic zinc(II) porphyrin incorporated into liposomes as models for biological electron transfer. KANEKO, M., Proc. Indian Acad. Sri., Chem. Sri., 1992, 104, (6), 723–730.
  • Comparison of the cardiotoxic effects of liposomal doxorubicin (TLC D-99) versus free doxorubicin in beagle dogs. KANTER, P. M., BULLARD, G. A., GINSBERG, R. A., PILKIEWICZ, F. G., MAYER, L. D., CuTus, P. R., and PAVELIC, Z. P., In vivo, 1993, 7, (1), 17–26.
  • Preclinical toxicology study of liposome encapculated doxorubicin (TLC D-99): comparison with doxorubicin and empty liposomes in mice and dogs. KANTER, P. M., BULLARD, G. A., PILKIEWICZ, F. G., MAYER, L. D., CULLIS, P. R., and PAVELIC, Z. P., In vivo, 1993, 7, (1), 85–95.
  • Establishment of hepatitis B virus model animals by HVJ-liposome method. KATO, K., Nippon Rinsho, 1993, 51, (2), 525–530.
  • Blood clearance and tissue distribution of various formulations of alpha-tocopherol injection after intravenous administration. KATO, Y., WATANABE, K., NAKAKURA, M., HOSOKAWA, T., HAYAKAWA, E., and I'm), K., Chem. Pharm. Bull. (Tokyo), 1993, 41, (3), 599–604.
  • Homogeneous immunoassay of polyclonal antibodies by use of antigen-coupled liposomes. KATOH, S., SOHMA, Y., MORI, Y., FUJITA, R., SADA, E., KISHIMURA, M., and FUKUDA, H., Biotechnol. Bioeng., 1993, 41, (9), 862–867.
  • Size control of ibuprofen microspheres with an acrylic polymer by changing the pH in an aqueous dispersion medium and its mechanism. KAWASH1MA, Y., lwAmoTo, T., NIWA, T., TAKEUCHI, H., and HINO, T., Chem. Pharm. Bull., 1993, 41, (1), 191–195.
  • Sequential therapy with chemotherapeutic drugs and liposome-encapsulated muramyl tripeptide: determination of potential interactions between these agents. KILLION, J. J., KLEINERMAN, E. S., WILSON, M. R., TANAKA, M., and FIDLER, I. J., Oncol. Res., 1992, 4, (10), 413–418.
  • The organ targetability of small and large albumin microspheres containing free and HSA conjugated methotrexate. KIM, C. K., HWANG, S. J., and LEE, M. G., Int. J. Pharm., 1993, 89, (2), 91–102.
  • Liposome immunoassay (LIA) with antigen-coupled liposomes containing alkaline phosphatase. KIM, C. K., and LEVI, S. J., J. Immunol. Methods, 1993, 159, (1-2), 101–106.
  • Fluorescence anisotropy studies on the interaction of the short chain n-alkanols with stratum corneum lipid liposomes (SCLL) and distearoylphosphatidylcholine (DSPC)/distearoylphosphatidic acid (DSPA) liposome. Kim, Y. H., HIGUCHI, W. I., HERRON, J. N., and ABRAHAM, W., Riochim. Biophys. Acta, 1993, 1148, (1), 139–151.
  • Preparation and characterization of poly(gamma-benzyl 1.-glutamate)/poly(ethylene oxide)-lactose lactone block copolymers and their microspheres. KIM, Y., Cm, C. S., SUNG, Y. K., CHUNG, B. H., and LEE, K. C., Yakche Hakhoechi, 22, (3), 237–240.
  • Magnetic targeting of a therapeutic antibody using magnetotropic microspheres of the interpolyelectrolyte coacervation complex. KIRPOTIN, D. B., KINNE, R., MILTON, A., PALOMBO, K. E., and EMMRICH, E., J. Magn. Magn. Mater., 1993, 122 (1-3), 354–359.
  • Liposome-based immunoassay for complement activity and its application to clinical tests. KISHIMURA, M., FUKUDA, H., KATOH, S., SADA, E., and TANIGUCHI, H., Biochem. Eng., 2001, Proc. Asia-Pac. Biochem. Eng. Conf. Springer, Tokyo, Japan, 1992, 639–641.
  • Liposome-encapsulated muramyl tripeptide: a new biologic response modifier for the treatment of osteosarcoma. KLEINERMAN, E. S., MAEDA, M., and JAFFE, N., Cancer Treat. Res., 1993, 62, 101–107.
  • Sensitive detection of ganglioside GD3 on the cell surface using liposome immune lysis assay. KOBAYASHI, K., WATARA1, S., and YASUDA, T., Acta Med. Okayarna, 1992, 46, (6), 435–441.
  • Preparation of membrane fractions and liposomes. KOBAYASHI, T., and INOUE, K., jikken Igaku, 1993, 11, (3), 209–215.
  • Activation of rainbow trout (Oncorhynchus mykiss) phagocytes by muramyl dipeptide. KODAMA, H., HIROTA, Y., MUKAMOTO, M., BABA, T., and AZUMA, I., Dev. Comp. Immunol., 1993, 17, (2), 129–140.
  • Continuous measurement of rat gastric blood flow using Doppler fiowmeter. KOERPER, J., BAUERFEIND, P., ARMSTRONG, D., and BLUM, A. L., Am. J. Physiol., 1993, 264 (4, Pt 1), G686–G692.
  • A method for rapid exchange of solutions at membrane patches using a 10-microliters microcapsule. KOH, D. S., and VOGEL, W Pflugers Arch., 1993, 422, (6), 609–613.
  • Photosensitized synthesis of ATP in suspensions of flavoproteinoid liposomes. KOLESNIKOV, M. P., Zh. Eval. Biokhim. Fiziol., 1992, 28, (3), 298–302.
  • Liposomes and their applications. III. The artificial red blood cell. KOLLAR, G., Gyogyszereszet, 1992, 36, (7), 405–409.
  • Increased activity and tolerability of a conventional glucocorticoid in a liposomal form. KORT1NG, H. C., Liposome Dermatics, Griesbach Conf., Springer, Berlin, Germany, 1993, 320–328.
  • An experimental study of the tumor affinity of gallium-67-labelled sphingomyelin liposomes. KOSTENIKOV, N. A., FADEEV, N. P., SERZHANINA, V. A., KORESAKOVA, L. N., and ROZENBERG, O. A., Vopr. Onkol., 1992, 38, (9), 1080–1084.
  • Polymeric microspheres-preparation, characteristics, and applications. KOWALCZYK, D., and SLomRowsxi, S., Polimery (Warsaw), 1992, 37, (10), 442–449.
  • Preparation and evaluation of pectin microcapsules with tocopherol acetate. KRALOVA, K., and MITTERBAUSZEROVA, L., Cesk. Farm., 1992, 41, (9-10), 320–331.
  • Delivery of liposome-encapsulated agents to artificial membranes. KREUTER, J., Liposome Dermatics, Griesbach, Conf., Springer, Berlin, Germany, 1992, 167–171.
  • Liposome production: the ethanol injection technique and the development of the first approved liposome dermatic. KRIFTNER, R. W Liposome Dermatics, Griesbach Conf., Springer, Berlin, Germany, 1992, 91–100.
  • Experimental studies on antitumor effect of transcatheter arterial embolization employing polyactic acid microspheres containing aclarubicin hydrochloride, and combination therapy involving transcatheter arterial embolization and portal embolization for VX2 carcinoma implanted into the rabbit liver. KURATATE, S., YOGITA, S., TAKAI, S., and TAKAGI, T., Shikoku Igaku Zasshi, 1992, 48, (4/5), 110–119.
  • Biodegradable starch microspheres for cerebral arterial embolization. LACCOURREYE, O., LAURENT, A., POLIVKA, M., WASSEF, M., DOMAS, L., BRASNU, D., and MERLAND, J. J., Invest. Radiol., 1993, 28, (2), 150–154.
  • Immunization against Echis ocellatus (carpet viper) venom using liposomes incorporating immunostimulants: role of lipopolysaccharide in conferring protection in a mouse model. LAING, G. D., and THEAKSTON, R. D. G., Toxicon, 1993, 31, (5), 615–626.
  • New vaccines for the world: needs and prospects. LAMBERT, P. H., Rev. Med. Suisse Romande, 1993, 113, (3), 193–198.
  • Study on dissolution characteristics of indomethacin-ethyl cellulose microcapsules. LEE, H. J., and Ku, Y. S., Nonchong-Han'guk Saenghwal Kwahak Yonguwon, 1992, 50, 207–236.
  • Aggregation of hapten-bearing liposomes mediated by specific antibodies. LEE, K. D., KANTOR, A. B., NIR, S., and OwicKI, J. C., Biophys. J, 1993, 64, (3), 905–918.
  • Microencapsulated LH-RH analog accelerated spermiation in protandrous black porgy, Acanthopagrus schlegeli. LEE, M. F., CHANG, C. F., HUANG, J. D., and SCHALLY, A. V., Bull. Inst. Zool., Acad. Sin., 1993, 32, (1), 32–38.
  • Duplex/colour Doppler sonography: measurement of changes in hepatic arterial haemodynamics following intra-arterial angiotensin II infusion. LEEN, E., ANGERSON, W. J., WARREN, H. W., GOLDBERG, J. A., SUTHERLAND, G. R., COOKE, T. G., and MCARDLE, C. S., Br. J. Cancer, 1993, 67, (6), 1381–1384.
  • Hepatic arterial haemodynamics changes following intra-arterial angiotensin H infusion: duplex/colour Doppler sonography. LEEN, E., ANGERSON, W. J., WARREN, H. W., GOLDBERG, J. A., LEIBERMAN, D. P., COOKE, T. G., and MCARDLE, C. S., Clin. Radiol., 1993, 47, (5), 321–324.
  • A novel microsphere formulation for adult diabroticine beetle pest management. LEW, C., LAMB, C., BRANLY, K., and GAGGERO, J., Proc. Int. Symp. Controlled Release Bioact. Mater., 19th, Controlled Release Soc., Deerfield, Ill, 1992, 439–440.
  • Targeted drug delivery. LEYLAND, J. B., Semin. Oncol., 1993, 20, (1), 12–17.
  • Poly(hydroxypropyl L-glutamate) microscpheres: potential targeting carriers. Li, C., KUANG, L. R., YANG, D., MCCUSKEY, P., and WALLACE, S., Proc. Int. Symp. Controlled Release Bioact. Mater., 19th, Controlled Release Soc., Deerfield, Ill, 1992, 389–390.
  • Liposomes can specifically target entrapped melanin to hair follicles in histocultured skin (letter). Li, L., LISHKO, V. K., and HOFFMAN, R. NI., In vitro Cell. Dev. Biol., 1993, 29A, (3 Pt 1), 192–194.
  • Liposome targeting of high molecular weight DNA to the hair follicles of histocultured skin: a model for gene therapy of the hair growth processes (letter). Li, L., Lislixo, V., and HOFFMAN, R. M., In vitro Cell. Dev. Biol., 1993, 29A, (4), 258–260.
  • The effect of gadolinium on the phase transition property of dipalmitoylphosphatidylcholine liposomes. Li, X., ZHANG, Y., Ni, J., CHEN, J., and HUANG, F., Chin Sci. Bull., 1992, 37, (13), 1088–1092.
  • Viral liposomes released from insect cells infected with recombinant baculovirus expressing the matrix protein of vesicular stomatitis virus. Li, Y., Luo, L., SCHUBERT, M., WAGNER, R. R., and KANG, C. Y., y. Virol., 1993, 67, (7), 4415–4420.
  • Cationic liposome-mediated incorporation of prostatic acid phosphatase protein into human prostatre carcinoma cells. LIN, NI. F., DAVoLio, J., and GARCIA, R., Biochem. Biophys. Res. Commun., 1993, 192, (2), 413–419.
  • Changes of microencapsulated garlic and ginger essential oils after storage. LIN, S. Y SHEEN, L. Y., and TSAI, S. J., Zhongguo Nongye Huaxue Huizhi, 1992, 30, (4), 544–552.
  • The resistance of liposomes as potential drug carriers to the action of phospholipase A2. LITVINKO, N. M., SHUMILINA, T. A., NAUBATOVA, M. K., and AKHREM, A. A., Prikl. Biokhim. Mikrobiol., 1993, 29, (3), 478–484.
  • Preparation of liposomes entrapping plasmid DNA and linear DNA. Liu, Q., Wu, M., SHEN, Z., YIN, C., and ZHAO, N., Zhongguo Yixue Kexueyuan Xuebao, 1992, 14, (3), 220–224.
  • Betaines as novel liposome cryoprotectants. LLOYD, A. W., OLLIFF, C. J., and RUTT, K. J., Proc. Int. Symp. Controlled Release Bioact. Mater., 19th, Controlled Release Soc., Deerfield, Ill, 1992, 385–386.
  • Effects of biomicrosphere on the cochlear blood flow, blood pressure and heart rate in guinea pigs. Lo, R. Z., Chung Hua Erh Pi Yen Hou Ko Tsa Chih, 1992, 27, (4), 216–218.
  • Liposome-based flow-injection immunoassay for determining theophylline in serum. LOCASCIO, B. L., PLANT, A. L., CHESLER, R., KROLL, M., RUDDEL, M., and DURST, R. A., Clin. Chem. (Washington, DC), 1993, 39, (3), 386–391.
  • Microcapsules of hydrophilic drug-cyclodextrin complexes. LoFTSSON, T., KRISTMUNDSDOTTIR, T., INGVARSDOTTIR, K., BALDVINSDOTTIR, J., and OLAFSDOTTIR, B. J., Proc. Int. Symp. Controlled Release Bioact. Mater., 19th, Controlled Release Soc., Deerfield, Ill, 1992, 359–360.
  • Microcapsules containing water-soluble cyclodextrin inclusion complexes of water-soluble drugs. LOFTSSON, T., and KRISTMUNDSDOTTIR, T., ACS Symp. Ser., 1993, 520 (Polymeric Delivery Systems), 168–189.
  • Intra-articular therapy of experimental arthritis with a derivative of triamcinolone acetonide incorporated in liposomes. LOPEZ, G. F., VAZQUEZ, A. J. M.,F., LATOORE, R., MORENO, F., VILLALAIN, J., and GOMEZ, F. J. c., J. Pharm. Pharmacol., 1993, 45, (6), 576–578.
  • Microspheres-properties and use. LUKWINSKI, L., and GULDAN, Z., Mater. Ogniotruale, 1992, 44, (1), 1–4.
  • Conjugation of apolipoprotein B with liposomes and targeting to cells in culture. LUNDBERG, B., HONG, K., and PAPAHADJOPOULOS, D., Biochim. Biophys. Acta, 1993, 1149, (2), 305–312.
  • Intravenous injections of beta-elemene-containing liposomes. MA, S., WANG, H., TANG, S., Xu, J., SONG, L., DING, Y., and Guo, Y., Zhongguo Yaoxue Zazhi, 1992, 27, (11), 660-662. A-ring oxidation products from gamma-irradiation of cholesterol in liposomes. MAERKER, G., and JONES, K. C., J. Am. Oil Chem. Soc., 1993, 70, (3), 255–259.
  • Preparation of microspheres for intra-articular administration. MAHATO, R. I., HALBERT, G. W., WILI,MOTT, N., and WHATELEY, T. L., Proc. Int. Symp. Controlled Release Bioact. Mater., 19th, Controlled Release Soc., Deerfield, III, 341–342.
  • Permeability through the nasal mucosa of rabbits of insulin entrapped in liposomes. MAITANI, Y., ASANO, S., NAKAGAKI, M., and NAGAI, T., Congr. Int. Technol. Pharm., 6th, Assoc. Pharm. Galenique Ind., Chatenay Malabry, Fr., 1992, 61–69.
  • Basic principles of liposomes for drug use. MARTIN, G. P., and LLOYD, A. W Liposome Dermatics, Griesbach Conf., Springer, Berlin, Germany, 1992, 20–26.
  • Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA. MARTiNioN, F., KRISHNAN, S., LENZEN, G., MAGNE, R., GOMARD, E., GUILLET, J. G., LEVY, J. P., and MEULIEN, P., Eur. J. Immunol., 1993, 23, (7), 1719–1722.
  • Enhanced delivery of doxorubicin to tumor by long-circulating thermosensitive liposomes and local hyperthermia. MARUYAMA, K., UNEZAKI, S., TAKAHASHI, N., and IWATSURU, M., Biochim. Biophys. Acta, 1993, 1149, (2), 209–216.
  • Protection against vaginal SIV transmission with microencapsulated vaccine. MARX, P. A., COMPANS, R. W., GETTIE, A., STAAS, J. K., GILLEY, R. M., MULLIGAN, M. J., YAMSCHIKOV, G. V., CHEN, D., and ELDRIDGE, J. H., Science, 1993, 260, (5112), 1323–1327.
  • Treatment of experimental invasive pulmonary aspergillosis in rats with liposomal amphotericin B. MATSUDA, H., KOHNO, S., MIYAZAKI, Y., IVIiTsuTAKE, K., TANAKA, K., MAESAKI, S., IwAmorro, M., HASHIMOTO, A., KAKI:, M., KOGA, H. et al., Kansenshogaku Zasshi, 1993, 67, (2), 102–109.
  • Specific inhibitory effect of hybrid liposomes on growth of human lymphoma-human lymphocyte B hybridoma cells in vitro. MATsumoTo, Y., YAMAHA, E., HIRANO, J., OSHIGE, M., 110, M., IWAHARA, M., and UEOKA, R., Biol. Pharm. Bull., 1993, 16, (2), 213–215.
  • Sugar-coated liposomes: a novel delivery system for increased drug efficacy and reduced drug toxicity. MEDDA, S., MUKHERJEE, S., DAS, N., NASKAR, K., MAHATO, S. B., and BASU, M. K., Biotechnol. Appl. Biochem., 1993, 17, (1), 37–47.
  • Influence of peroxidation products of liposomal lipids on antibacterial activity of liposomes. MELYANTSEVA, L. P., KREINES, V. M., SHRAER, T. I., LAGUNOVA, N. T., and ULYANTSEVA, I. M., Antibiot. Khinaoter., 1992, 37, (11), 8–10.
  • Biodegradation and brain tissue reaction to poly(D,L-lactide-co-glycolide) microspheres. MENEI, P., DANIEL, V., MONTERO-MENEI, C., BROUILLARD, M., POUPLARD-BARTHELAIX, A., and BENOIT, J. P., Biomaterials, 1993, 14, (6), 470–478.
  • In vitro and in vivo study of phenobarbitone sodium microcapsules with Eudragit RS. MESHALI, M. M., EL-HELW, A. E., and EL-FATTAH, E. A., Acta Pharm. Fenn., 1992, 101, (3), 135–140.
  • A study on different systems for the preparation of microcapsules of water soluble drug using Eudragit RS as a wall forming material. MEsnALI, M. M., Ei.-FIELw, A. E., and EL-FATTAH, E. A., Acta Pharm. Fenn., 1992, 101, (3), 127–134.
  • Preparation and characterization of cisplatin-loaded poly(methyl methacrylate) microspheres. MESTIRI, M., PUISIEUX, F., and BENorr, J. P., Int. J. Pharm., 1993, 89, (3), 229–234.
  • Comedolytic activity of a liposomal antiacne drug in an experimental model. MEYBECK, A., Liposome Dermatics, Griesbach Conf., Springer, Berlin, Germany, 1992, 233–241.
  • Pupal blood flow: use of radio-labelled microspheres. MEYER, M. W., Int. Endod. I., 1993, 26, (1), 6–7.
  • Liposomes and nanoparticles as ocular drug delivery systems. MEZEI, M., and MEISNER, D., Biopharm. Ocul. Drug Delivery, CRC, Boca Raton, Fla., 1993, 91–104.
  • Temperature studies of glyceraldehyde-3-phosphate dehydrogenase binding to liposomes using a fluorescence technique. MICHALAK, K., GuTowlcz, J., and MODRZYCKA, T., Gen, Physiol. Biophys., 1992, 11, (6), 545–554.
  • Liposomes and conjugate vaccines for antigen delivery and induction of mucosal immune responses. MICHALEK, S. M., CHILDERS, N. K., KATZ, J., DERTZBAUGH, M., ZHANG, S., RUSSELL, M. W., MACRINA, F. L., JACKSON, S., and MESTECKY, J., Adv. Exp. Med. Biol., 1992, 327 (Genetically Engineered Vaccines), 191–198.
  • Plasma clearance of liposomes in rats. MicKLus, M. J., GREIG, N. H., TUNG, J., and RAPOPORT, S. I., Proc. Int. Symp. Controlled Release Bioact. Mater., 19th, Controlled Release Soc., Deerfield, Ill, 1992, 353–354.
  • Prolongation of corneal allograft survival with liposome-encapsulated cyclosporine in the rat eye. MILAN, J. K., PLEYER, ET., DUKES, A., CHOU, H. J., LUTZ, S., RUCKERT, D., SCHNIIDT, K. H., and MoNDtm), B. J., Ophthalmology, 1993, 100, (6), 890–896.
  • Dye release from laser irradiated liposomes. MISRA, P., HOLT, M., and MIsRA, S., Spectrosc. Lett., 1993, 26, (2), 375–387.
  • Effects of naftidrofuryl oxalate on microsphere embolism-induced changes in tricarboxylic acid cycle intermediates of rats. MIYAKE, K., TANONAKA, K., NASA, Y., TAKAGI, N., TSUCHIYA, T., YOSHIZAWA, M., EUDOKA, Y., and TAKEO, S., Eur. J. Pharntacol., 1993, 235, (1), 75–81.
  • Antitumor effect of fibrinogen microspheres containing mitomycin C against sarcoma-180 ascites carcinoma in mice. MIYAZAKI, S., OHKAWA, Y., ODA, M., TAKADA, M., SASAKI, M., and MIYAKAWA, A., Yakuzaigaku, 1992, 52, (4), 207–214.
  • Polysaccharide-coated liposomal amphotericin B for the treatment of murine pulmonary candidiasis. MIYAZAKI, T., K0146;c), S., SASAYAMA, K., INot:F., Y., HARA, K., OGASAWARA, M., SATO, T., and SUNAMOTO, J., Tohoku y. Exp. Med., 1992, 168, (3), 483–490.
  • Purification and quantitative determination of carboxymethyl chitin incorporation into submicron bilayer-lipid membrane artificial cells (liposomes) encapsulating hemoglobin. MoBED, M., and CHANG, T. M. S., Biomater., Arti, f. Cells, Immobilization Biotechnol., 1992, 20, (2-4), 369–376.
  • Calorimetric, infrared spectroscopic, and scanning electron microscopic investigations of cryoprotected lyophilized liposomes. M()BLEY, W. C., and SCHREIER, H., Proc. Int. Symp. Controlled Release Bioact. Mater., 19th, Controlled Release Soc., Deerfield, Ill, 1992, 250–251.
  • An investigation of the filtration capacity and the fate of large filtered sterically-stabilized microspheres in rat spleen. MoGHImi, S. M., HEDEMAN, H., MUIR, I. S., ILLUM, L., and DAVIS, S. S., Biochim. Biophys. Acta, 1993, 1157, (3), 233–240.
  • Serum factors that regulate phagocytosis of liposomes by Kupffer cells. MOGIIINII, S. M., and PATEL, H. M., Biochem. Soc. Trans., 1993, 21, (2), 128S.
  • Liposome mediated delivery of gallium in vitro. MONKKONEN, J., BROWN, C. S., and HEATH, T. D., Proc. Int. Symp. Controlled Release Bioact. Mater., 19th, Controlled Release Soc., Deerfield, Ill, 1992, 349–350.
  • Liposomal hamycin in the control of experimental aspergillosis in mice: effect of phosphatidic acid with and without cholesterol. MooNis, M., AHIMAD, I., and BACHHAWAT, B. K.,.7. Antimicrob. Chemother., 1993, 31, (4), 569–579.
  • Immunotargeting of liposomes containing lipophilic antitumor prodrugs. Mom, A., KENNEL, S. J., and HUANG, L., Pharm. Res., 1993, 10, (4), 507–514.
  • Practice of the flow measurement using nonradioactive microspheres and X-ray fluorescence spectrometer. MORI, H., HARUYAMA, S., SHINOZAKI, Y., SAKAmoTo, H., CHLTJvo, M., and KUWAHIRA, I., Kokyu To junkan, 1993, 41, (5), 447–450.
  • Enteral insulin delivery by microspheres in 3 different formulations using Eudragit L100 and S100. MORISHITA, I., MORISHITA, M., TAKAYAMA, K., MACHIDA, Y., and NAGAI, T., Int. y. Pharm., 1993, 91, (1), 29–37.
  • Osmotic properties of large unilamellar vesicles prepared by extrusion. Mut, B. L., P. R., EVANS, E. A., and MADDEN, T. D., Biophys. y., 1993, 64, (2), 443–453.
  • Specificity of amphiphilic anionic peptides for fusion of phospholipid vesicles. MURATA, M., TAKAHASHI, S., SHIRAI, Y., KAGIWADA, S., HISHIDA, R., and ORNIstil, S., Biophys. y., 1993, 64, (3), 724–734.
  • Recent advance of liposomes. Preparation for cosmetics. NAITO, N., and HAYASI II, T., Fragrance 7., 1993, 21, (4), 70–78.
  • The influence of liposome-incorporated procaine on the membrane potential in high-potassium medium. NEACSU, I., and ZANOAGA, C. V., Rev. Roum. Biol., Ser. Biol. Anim., 1992, 37, (2), 119–124.
  • A basic study on the hybridoma cell culture of microencapsulation. NiNc;, G., QIAN, J., and Guo, M., Chin. J. Biotechnol., 1992, 8, (2), 131–137.
  • Evidence that Muller cells can phagocytize egg-lecithin-coated silicone particles. NISHIZONO, H., MURATA, Y., TANAKA, M., Soil, T., and HERBERT, D. C., Tissue Cell, 1993, 25, (2), 305–310.
  • Influence of block copolymers on the adsorption of plasma proteins to microspheres. NORMAN, M. E., WILLIAMS, P., and ILLum, L., Biomaterials, 1993, 14, (3), 193–202.
  • Intravaginal immunization in sheep using a bioadhesive microsphere antigen delivery system. O'HAGAN, D. T., RAFFERTY, D., WHARTON, S., and ILLum, L., Vaccine, 1993, 11, (6), 660–664.
  • Magnetic microcapsule exploration in the gastrointestinal cavity of the origins of colorectal cancer-associated DNA-damaging agents in the human diet. O'NEILL, I., BINGHAM, S., ELLUL, A., and INCAURGARAT, B., Environ. Health Perspect., 1993, 99, 161–167.
  • Active removal of radioactivity in the blood circulation using biotin-bearing liposomes and avidin for rapid tumor imaging. OGIHARA, U. I., SASAKI, T., and NISHIGORI, H., Eur. y. Nucl. Med., 1993, 20, (2), 170–172.
  • Occlusion of retinal vessels using targeted delivery of a platelet aggregating agent. OGURA, Y., GDRAN, T., TAKAILAsHI, K., and ZEIMER, R., Br. y. ophrhaimat., 1993, 77, (4), 233–237.
  • Cytotoxicity of adriamycin-containing immunoliposomes targeted with anti-ganglioside monoclonal antibodies. OHTA, S., IGARASHI, S., HONDA, A., SATO, S., and HANAI, N., Anticancer Res., 1993, 13, (2), 331–336.
  • Experimental study on antitumor effect of cisplatin-microcapsule. OHTA, S., SATo, S., SAITO, Y., and FUKUSHI, A., Nippon Sanka Fujinka Gakkai Zasshi, 1993, 45, (3), 205–212.
  • Release behavior of 5-fluorouracil from chitosan gel microspheres immobilizing 5-fluorouracil derivative coated with polysaccharides and their cell specific recognition. OHYA, Y., TAKEI, T., KOBAYASHI, H., and Ouciii, T., j. Microencapsulation, 1993, 10, (1), 1–9.
  • Characterization of PGE1 preparation of lipid microsphere (Lipo PGE1) from a pharmacological viewpoint. OKAMOTO, H., HAMANO, T., and YOKOYAMA, K., Essent. Fatty Acids Eicosanoids, Invited Pap. Int. Congr., 3rd, AOCS, Champaign, Ill, 1992, 373–378.
  • Tumor imaging with technetium-99m-DTPA encapsulated in RES-avoiding liposomes. OKU, N., NAMBA, Y., TAKEDA, A., and OKADA, S., Nucl. Med. Biol., 1993, 20, (4), 407–412.
  • Liposome, and its application. OKUMURA, Y., and SUNAMOTO, J., Kobunshi Kako, 1992, 41, (10), 490–497.
  • A minimal model of ion channels: polyamino acids in liposomes. OLIVER, A. E., and DEAMER, D. W., Jerusalem Symp. Quantum Chem. Biochern., 1992, 25 (Membrane Proteins: Structures, Interactions and Models), 339–356.
  • Effect of crosslinked core on minimum film formation temperature and morphology of composite microspheres. Omi, S., KOHNIOTO, T., and Iso, M., Polym. Int., 1993, 30, (4), 499–504.
  • Optimization of conditions for preparing 2- to 5-micron-range gelatin microparticles by using chilled dehydration agents. ONER, L., and GROVES, M. J., Pharm. Res., 1993, 10, (4), 621–626.
  • A sensitive new fluorescence assay for measuring proton transport across liposomal membranes. OROSZ, D. E., and GARI,ID, K. D., Anal. Biochem., 1993, 210, (1), 7–15.
  • Tuftsin-bearing liposomes as drug vehicles in the treatment of experimental aspergillosis. OWAIS, M., AHMED, I., KRISIINAKUMAR, B., JAIN, R. K., BACHHAWAT, B. K., and GUPTA, C. M., FEBS Lett., 1993, 326, (1-3), 56–58.
  • Effect of collagen on liposome permeability. PAJEAN, M., and HERBAGE, D., Int. y. Pharm., 1993, 91, (2-3), 209–216.
  • The mechanics of axially symmetric liposomes. PAMPLONA, D. C., and CALLADINE, C. R., .7. Biomech. Eng., 1993, 115, (2), 149–159.
  • Preparation and characteristics of phosphatidylcholine liposomes covalently coupled with immunoglobulin fragments. PARK, J. H., LEE, E. O., and KIM, J. D., Yakche, Hakhoechi, 1992, 22, (2), 115–124.
  • Effect of chemically modified GM1 and neoglycolipid analogs of GM1 on liposome circulation time: evidence supporting the dysopsonin hypothesis. PARK, Y. S., and HUANG, L., Biochim, Biophys. Acta, 1993, 1166, (1), 105–114.
  • Liposome phospholipids: toxicological and environmental advantages. PARNHAM, M. J., Liposome Dermatics, Griesbach Conf., Springer, Berlin, Germany, 1992, 57–65.
  • The presence of GM1 in liposomes with entrapped doxorubicin does not prevent RES blockade. PARR, M. J., BALLY, M. B., and CuLLis, P. R., Biochim. Biophys. Acta, 1993, 1168, (2), 249–252.
  • Liposome immune lysis assay (LILA) for gelonin. PAUL, A., MADAN, S., VASANDANI, V. M., GHOSH, P. C., and BAcHHAwAT, B. K., y. Immunol. Methods, 1992, 148, (1-2), 151–158.
  • Binding of phospholipase C delta 1 to phospholipid vesicles. PAWELCZYK, T., and LOWENSTEIN, J. M., Biochem. y., 1993, 291, (Pt 3), 693–696.
  • Pharmacokinetics and pharmacodynamics of a parenteral testosterone microsphere formulation in the male rat. Demonstration of dose dependence and controlled release. PEACOCK, N. R., SWERDLOFF, R. S., BERMAN, N., GILLEY, R. M., TICE, T. R., and BHASIN, S., J. Androl., 1993, 14, (1), 45–52.
  • Cationic liposome-medited transfection of immune effector cells. PHILIP, R., and DEBS, R., y. Liposome Res., 1993, 3, (1), 71–84.
  • Structure of spherical liposome bilayers. POPESCU, D., Stud. Cercet. Fiz., 1992, 44, (5), 463–469.
  • Liposomes with magnesium salts. POPOVICI, A., and HOBAI, S., Congr. Int. Technol. Pharm., 6th, Assoc. Pharm. Galenique Ind., Chatenay Malabry, Fr., 1992, 341–345.
  • Comparison of adriamycin and derivatives uptake into large unilamellar lipid vesicles in response to a membrane potential. PRAET, M., DEFRISE-QUERTAIN, F., and RUYSSCHAERT, J. M., Biochim. Biophys. Acta, 1993, 1148, (2), 342–350.
  • Liposomal daunorubicin treatment of HIV-associated Kaposi's sarcoma. PRESANT, C. A., SCOLARO, M., KENNEDY, P., BLAYNEY, D. W., FLANAGAN, B., LISAK, J., and PRESAN'E, J., Lancet, 1993, 341, (8855), 1242–1243.
  • Nanoparticles monolayer phospholipid liposomes. PROSERPIO, G., SCARLATINI, G., and WEDER, H. G., Cosmet. Toiletries, Ed. Ital., 1992, 13, (3), 43, 46–48.
  • Magnetically induced orientation of phosphatidylcholine membranes. Qiu, X., MIRAU, P. A., and PIDGF,ON, C., Biochim. Biophys. Acta, 1993, 1147, (1), 59–72.
  • Synthesis, properties and intratumoral evaluation of drug-loaded protein microspheres. QULGG,1. M., KNEPP, W. A., JAYAKRisliNAN, A., SITREN, H. S., BAGNALL, J. J., MENTAK, K., FARNWORTH, S. T., YAIIIAOUI, A., and GOLDBERG, E. P., Proc. Int. Symp. Controlled Release Bioact. Mater., 19th, Controlled Release Soc., Deerfield, Ill, 1992, 156–157.
  • New prospects in the development of liposomes. II. Therapeutic applications. REY-SEIJO, B., GUTIERREZ DE RUBALCAVA, C., and VILA-.IATO, J. L., Farm. Clin., 1991, 8, (7), 601–603. 607–610. 612–613.
  • Peanut agglutinin purging and magnetic microspheres. RHODES, E. G. H., BAKER, P. K., DUGUID, J. K. M., and CAWLEY, J. C., Frog. Clin. Biol. Res., 1992, 377 (Advances in Bone Marrow Purging and Processing), 139–146.
  • Pharmacokinetics of liposomal nystatin in patients with human immunodeficiency virus infection (letter). Rios, A., ROSENBLUM, M., CROFOOT, G., LENK, R. P., HAYNIAN, A., and LOPEZ-BERESTEIN, G., y. Infect. Dis., 1993, 168, (1), 253–254.
  • Alamethicin as a permeabilizing agent for measurements of CA(2 + )-dependent ATPase activity in proteoliposomes, sealed membrane vesicles, and whole cells. RITOV, V. B., MURZAKHMETOVA, M. K., TVERDISLOVA, I. L., MENSHIKOVA, E. V., BUTYLIN, A. A., AVAKIAN, T. Yu, and YAKOVENKO, L. V., Biochim. Biophys. Acta, 1993, 1148, (2), 257–262.
  • Properties and characterization of pre-liposome systems. ROEDING, J., Liposome Dermatics, Griesbach Conf., Springer, Berlin, Germany, 1992, 110–117.
  • The liposome partitioning system for correlating biological activities of imidazolidine derivatives. ROGERS, J. A., and CH01, Y. W., Pharm. Res., 1993, 10, (6), 913–917.
  • Degradable starch microspheres in cytostatic treatment of a liver carcinoma; experimental studies in rats with 5-fluorouracil, tauromustine, carmustine, doxorubicin and R SU–1069.
  • Roos, G., CHRISTENSSON, P. I., EL HAG, I. A., JAKOBSSON, B., TEDER, H., and STENRAM, H., Anticancer Res., 1993, 13, (3), 635–641.
  • Oligmucleotides encapsulated in pH sensitive liposomes are efficient toward Friend re trovirus. (Erratum to document cited in CA116(20): 200975x). ROPERT, C., LAVIGNON, M., DUBERNET, C., COUVREUR, P., and MALVY, C., Biochem. Biophys. Res, Common., 1993, 192, (2), 982.
  • A liposome based platelet substitute, the plateletsome, with hemostatic efficacy. RYBAK, M. E., and RENZULIA, L. A., Biomater. Artif. Cells Immobilization Biotechnol., 1993, 21, (2), 101–118.
  • Protection against hydrophobic bile salt-induced cell membrane damage by liposomes and hydrophilic bile salts. SAGAWA, H., TAZUMA, S., and KAJIYAMA, G., Am. y. Physiol., 1993, 264, (5, Pt 1), G835–G839.
  • Evaluation of a microreservoir-type biodegradable microcapsule for controlled release of proteins. SAH, H., and CHIEN, Y. W., Drug. Den. Ind. Pharm., 1993, 19, (11), 1243–1263.
  • Recent aspects in the use of liposomes in biotechnology and medicine. SATO, 'P., and SUNAMOTO, J., Prog. Lipid Res., 1992, 31, (4), 345–372.
  • Clinical trial protocols for anti-inflammatory and other liposome dermatics. SCHAEFER, K. M., Liposome Dermatics, Griesbach Conf., Springer, Berlin, Germany, 1992, 299–307.
  • Lipid flow phenomena between liposomes, lipoproteins and cell membranes; applications in drug delivery. SCHERPHOF, G. L., MARUYAMA, K., VAN BORSSUM, W. M., HOEKSTRA, D., DAMEN, J., KENNEL, S. J., and HUANG, L., Liposome Dermatics, Griesbach Conf., Springer, Berlin, Germany, 1992, 11–19.
  • The fate of liposomes for topical use in skin tissue culture. SCHMID, M. H., Liposome Dermatics, Griesbach, Conf., Springer, Berlin, Germany, 1992, 195–199.
  • Liposomes for oral use. 3. Encapsulation, stability, and in vivo testing of streptokinase-containing liposomes for oral use. SCHMIDT, P. C., and MICHAELIS, J., PZ Wiss., 1992, 5, (5), 189–197.
  • Ceramides for liposomes. SCHMIDT, R. R., Liposome Dermatics, Griesbach Conf., Springer, Berlin, Germany, 1992, 44–56.
  • Labeling of liposomes with intercalating perylene fluorescent dyes. SCHOTT, H., VON CONOW, D., and LANGHALS, H., Biochim. Biophys. Ada, 1992, 1110, (2), 151–157.
  • Effects of various formulation parameters on the characteristics of liposomes obtained by a freeze/thaw procedure. SEW], B., GUTIERREZ DE RUBALCAVA, C., and VILA-,IATO, J. L., Congr. Int. Technol. Pharm., 6th, Assoc. Pharm. Galenique Ind., Chatenay Malabry, Fr., 1992, 333–340.
  • Model studies directed toward the boron neutron-capture therapy of cancer: boron delivery to murine tumors with liposomes. SHELLY, K., FEAKES, D. A., HAWTHORNE, M. F., SCHMIDT, P. G., KRISCH, T. A., and BAUER, W. F., Proc. Natl. Acad. Sci. USA, 1992, 89, (19), 9039–9043.
  • Vapor-phased release behavior of malathion in microcapsules. SHEN, D., TANG, A., LI, F., YANG, L., and LAI, H., Zhejiang Gongxueyuan Xuebao, 1992, (2), 9–14.
  • Development of target-specific drug delivery systems using glycosylated proliposome I binding of asialofetuin-labeled liposomes to lectin RCA. SHIM, C. K., LEE, C. Y., and KIM, C. K., Yakche Hakhoechi, 1992, 22, (2), 155–161.
  • Transplantation of free and microencapsulated islets in rats: evidence for the requirement of an increased islet mass for transplantation into the peritoneal site. SIEBERS, U., HORCHER, A., BRETZEL, R. G., KLocK, G., ZIMMERMANN, U., FEDERLIN, K., and ZEKORN, T., Int. y. Artif. Organs, 1993, 16, (2), 96–99.
  • Stability of acrylic resin nifedipine microspheres. SliNA, B. O., 1111(AI,, A. H., CLEARY, R. W., JONES, A. B., and DAVIS, W. M., Pharm. Ind., 1992, 54, (7), 643–644.
  • Applications of lipid-coated microbubble ultrasonic contrast to tumor therapy. SIMON, R. H., Ho, S. Y., LANGE, S. C., UPHOFE, D. F., and D'ARRIGO, J. S., Ultrasound Med. Biol., 1993, 19, (2), 123–125.
  • Comparison of liposome fusion and electroporation for the intracellular delivery of nonpermeant molecules to adherent cultured cells. SIMON, W. C., RAPTIS, L., PANG, S. C., and BENNETT, B. m., y. Pharmacol. Toxicol. Methods, 1993, 29, (1), 29–35.
  • SIMS analysis of fused clay microspheres containing plutonium. SIMONS, D. S., Second Ion Mass Spectrom., SIMS 8, Proc. Int. Conf., 8th, Wiley, Chichester, UK, 1992, 715–718.
  • Liposomal drug delivery to the eye and lungs: a preliminary electron microscopy study. SINGH, M., MEISNER, D., FAULKNER, G., and MEZEI, M., y. mi....a/mutation, 1993, 10, (1), 35–44.
  • Lung retention of phosphatidylcholine and cholesterol from liposomes: effects of oxygen exposure and fasting. SMITH, L. J., and ANDERSON, J., J. Appl. Physiol., 1993, 74, (4), 1899–1904.
  • ADP modifies the function of the glucose transporter: studies within reconstituted liposomes. SOPUE, M., YOSHIMURA, Y NISHIDA, M., and KAWADA, J., Biochem. y., 1993, 292, (Pt 3), 877–881.
  • Study of the properties of gelatin microcapsules obtained in the presence of various materials. Soy ILI, V., DJAKOVIC, L., and Doxic, P., Zb. Rad.-Technol. Fak. Novorn. Sac/u, 1991, 22, 45–52.
  • Influence of surfactant-protein interaction on the wall structure of microcapsules. Sovii.j, V., DJAKOVIC, L., and Doxic, P., y. Colloid Interface Sci., 1993, 158, (2), 483–487.
  • Studies on the tissue distribution of liposome-associated clofazimine, and antileprosy drug. SRITHARAN, M., Methods Find. Exp. Clin. Pharmacol., 1993, 15, (2), 107–111.
  • Myelin-liposome protection against experimental autoimmune encephalomyelitis is associated with reduced neuroantigen-specific T-cell-mediated response. STEIN, C. S., ST LOUIS, J., and STREJAN, G. H., Cell Immunol., 1993, 146, (1), 80–95.
  • Exposure of galactosylceramide to galactose oxidase in liposomes: dependence on lipid environment and ceramide composition. STEWART, R. J., and B000s, J. M., Biochemistry, 1993, 32, (21), 5605–5614.
  • Preparation of biodegradable poly(lactic-co-glycolic acid) microspheres and their in vitro release of timolol maleate. STurtEssoN, C., CARLFORS, J., EDSMAN, K., and ANDERSSON, M., Int. y. Pharm., 1993, 89, (3), 235–244.
  • The gastrointestinal absorption of griseofulvin can be enhanced by encapsulation into liposomes. SUE, M. S., Liu, K. M., and Yu, H. S., Gaoxiong Yixue Kexue Zazhi, 1993, 9, (1), 1–8.
  • Gastric emptying rate of drug preparations. HI. Effects of size of entric microcapsules with mean diameters ranging from 0.1 to 1.1 mm in man. SUGITO, K., OGATA, H., GOTO, H., KANIWA, N., TAKAHATA, H., and SAMEJIMA, M., Chem. Pharm. Bull., 1992, 40, (12), 3343–3345.
  • Naturally occurring polysaccharide derivatives which behave as an artificial cell wall on an artificial cell liposome. SUNAMOTO, J., SATO, T., TAGUCHI, T., and HAMAZAK I, H., Macromolecules, 1992, 25, (21), 5665–5670.
  • Pulmonary uptake of liposome-associated alpha-tocopherol following intratracheal instillation in rats. SUNTRES, Z. E., HEPWORTH, S. R., and SliEK, P. N., J. Pharm. Pharmacol., 1993, 45, (6), 514–520.
  • Hydronium ion diffusion into microcapsules and its effect on the pH of encapsulated aqueous solutions. Theoretical analysis. SVOBODA, G. D., THIES, C., CHENG, P. S., ZHOU, J., ASIF, M., and DISTELRATH, D. L., ACS Symp. Ser., 520 (Polymeric Delivry Systems), 1993, 265–273.
  • Polyanhydride microspheres that display near-constant release of water-soluble model drug compounds. TABATA, Y., and LANGER, R., Pharm. Res., 1993, 10, 3), 391–399.
  • Controlled delivery systems for proteins using polyanhydride microspheres. TABATA, Y., GUTTA, S., and LANGER, R., Pharm. Res., 1993, 10, (4), 487–496.
  • Fe3+ binding to liposomes of different phospholipid composition. TADOLINI, B., MoTTA, P., and Rossi, C. A., Biochem. Mol. Biol. Int., 1993, 29, (2), 299–305.
  • Preparation of microspheres in micron size range by dispersion polymerization of methacrylic acid esters in mixed hydrophilic solvents. TAKAHASHI, K., and MivAmoRi, S., Kobunshi Ronbunshu, 1993, 50, (4), 243–250.
  • Microspheres prepared with a temperature-responsive macromonomer. TAKEUCHI, S., OIKE, M., KOWITZ, C., SHINIASAKI, C., HASEGAWA, K., and KITANO, H., Makromol. Chem., 1993, 194, (2), 551–558.
  • Liposomes as drug delivery systems. Part 3: stabilization. TALSMA, H., and CROMMELIN, D. J. A., BioPharm. (Eugene, Oreg.), 1993, 6, (2), 40–42. 44, 46.
  • A birth control vaccine is on the horizon for family planning. TAMAR, G. P., SINGH, O., PAL, R., CHATTERJEE, N., UPADHYAY, S. N., KAUSHIC, C., GARG, S., KAUR, R., SINGH, M., CHANDRASEKHAR, S. et al., Ann. Med., 1993, 25, (2), 207–212.
  • Cholesterol is required for the fusion of single unilamellar vesicles with Mycoplasma capricolum. TARSHIS, M., SALMAN, M., and ROTTENI, S., Biophys. y., 1993, 64, (3), 709–715.
  • Fluorescent fiber-optic immunosensing system based on complement lysis of liposome containing carboxyfluorescein. TATSU, Y., YAIVIAMURA, S., and YOSHIKAWA, S., Biosens. Bioelectron, 1992, 7, (10), 741–745.
  • Polymeric microspheres for controlled-release herbicide formulations. TEFFT, J., and FRIEND, D. R., ACS Symp. Ser., 520 (Polymeric Delivery Systems), 1993, 190–201.
  • Liposome-enhanced tumour therapy in canine mammary gland tumours. TESKE, E., and RUTTEMAN, G. R., Tijdschr. Diergeneeskd, 1993, 118, Suppl. 1, 32S–33S.
  • Modulation of doxorubicin resistance in multidrug-resistant cells by liposomes. THIERRY, A. R., VICE, D., COUGHLIN, S. S., BELLI, J. A., DRITSCHILO, A., and RAHMAN, A., FASEB y., 1993, 7, (6), 572–579.
  • Overcoming multidrug resistance in human tumor cells using free and liposomally encapsulated antisense oligodeoxynucleotides. THIERRY, A. R., RAIIMAN, A., and DRI'I'SCHILO, A., Biochem. Biophys. Res. Commun., 1993, 190, (3), 952–960.
  • Liposome dermatics: assessment of long-term stability. THOMA, K., and Joel-1Am, U. E., Liposome Dermatics, Griesbach Conf., Springer, Berlin, Germany, 1992, 150–166.
  • Electron microscopy of cytochrome c oxidase-containing proteoliposomes: imaging analysis of protein orientation and monomer-dimer behaviour. TIHovA, M., TATTRIE, B., and NieHou-s, P., Biochem. 1, 1993, 292, (Pt 3), 933–946.
  • Polymer-derivatized technetium-99m-labeled liposomal blood pool agents for nuclear medicine applications. TILCOCK, C., AHKONG, Q. F., and FISHER, D., Biochim. Biophys. Acta., 1993, 1148, (1), 77–84.
  • Gene therapy, concepts, current trials and future directions. TOLSTOSHEV, P., Annu. Rev. Pharmacol. Toxicol., 1993, 33, 573–596.
  • Uptake of phosphatidylserine liposomes by rat Peyer's patches following intraluminal administration. TomizAwA, H., ARAMAKI, Y., FUJI', Y., HARA, T., SUZUKI, N., YACHI, K., KIKUCHI, H., and TSUCFIIYA, S., Pharm. Res., 1993, 10, (4), 549–552.
  • Interaction between oleic acid-containing pH-sensitive and plain liposomes. Fluorescent spectroscopy studies. TORCHILIN, V. P., LUKYANOV, A. N., KLIBANOV, A. L., and OA4ELYANENKO, V. G., FEBS Lett., 1992, 305, (3), 185–188.
  • In vitro drug release of vitamin A microcapsules. TORRADO, J. J., TORRADO, S., FRUTOS, G., and CADORNIGA, R., Proc. Int. Symp. Controlled Release Bioact, Mater., 19th, Controlled Release Soc., Deerfield, III, 1992, 363–364.
  • Use of solid-phase liposomal immunoassay for the determination of bacterial antigens of lipopolysaccharide nature. TRETYAKOV, S. I., YARKOV, S. P., ZLOBIN, V. N., and KALININ, Yu T., Zh. Mikrobiol., Epidemiol. Immunobiol., 1992 (11–12), 43–46.
  • Calcineurin trapped in liposomes inhibits the action potentials of isolated 3-days-old embryonic chick ventricle. TRIPATHI, O., and SPERELAKIS, N., J. Dev. Physiol., 1992, 18, (3), 121–124.
  • Microsphere encapsulated 1-asorbic acid: its effects on erythrocytes during 56 days storage. TRUTER, E. J., Biomater. Artif. Cells, Immobilization Biotechnol., 1992, 20, (2-4), 1107–1109.
  • One continuous process of agglomeration and microencapsulation for enoxacin. Preparation method and mechanism of microencapsulation. UEDA, M., NAKAMURA, Y., MAKITA, H., and KAWASHIMA, Y., J. Microencapsulation, 1993, 10, (1), 25–34.
  • Mobility and molecular orientation of vitamin E in liposomal membranes as determined by 19F NMR and fluorescence polarization techniques. URANO, S., MATSU°, M., SAKANAKA, T., UEMURA, T., KOYAMA, M., KUMADAKI, I., and FUKUZAWA, K., Arch. Biochem. Biophys., 1993, 303, (1), 10–14.
  • Studies on glucosylceramidase binding to phosphatidylserine liposomes: the role of bilayer curvature. VACCARO, A. M., TATTI, M., CIAFTONI, F., SALVIOLI, R., BARCA, A., and RONCAIOLI, P., Biochim. Biophys. Acta, 1993, 1149, (1), 55–62.
  • Microsphere-based short-wavelength recombination X-ray laser. VALEO, E. J., and COWLEY, S. C., Phys. Rev. E: Stat. Phys., Plasma, Fluids, Re/at. Interdiscip. Top., 1993, 47, (2), 1321–1336.
  • In vitro stability and cytostatic activity of liposomal formulations of 5-fluoro-2'-deoxyuridine and its diacylated derivatives. VAN BORSSUM-WAALKES, M., VAN GALEN, M., MORSELT, H., STERNBERG, B., and SCHERPHOF, G. L., Biochim. Biophys. Acta, 1993, 1148, (1), 161–172.
  • Reversible depletion of synovial lining cells after intra-articular treatment with liposome-encapsulated dichloromethylene diphosphonate. VAN LENT, P. L., VAN DEN BERSSELAAR, L., VAN DEN HOER, A. E., VAN DE ENDE, M., DIJKSTRA, C. D., VAN ROOIJEN, N., VAN DE PUTTE, L. B., and VAN DEN BERG, W. B., Rheumatol. Int., 1993, 13, (1), 21–30.
  • Efficacy of various water-soluble chelator molecules in the liposome-mediated macrophage 'suicide' technique. VAN ROOIJEN, N., and POPPEMA, A., y. Pharmacol. Toxicol. Methods, 1992, 28, (4), 217–221.
  • Analysis of release data in the evaluation of the physical state of progesterone in matrix systems. VANDELLI, M. A., FORNI, F., and CAMERON, R., J. Microencopsulation, 1993, 10, (1), 55–66.
  • Host reaction against alginate-polylysine microcapsules containing living cells. VANDENBOSSCHE-GEERT, M. R., BRACKE, M. E., CUVELIER, C. A., BORTIER, H. E., MAREEL, M. M., and REmoN, J.-P., J. Pharm. Pharmacol., 1993, 45, (2), 121–125.
  • Development of a delivery system for carboxylic ionophores: a potentiator of immunotoxin toxicity using liposome as a carrier. VASANDANI, V. M., MADAN, S., and GHOSH, P. C., Biochem. Eng. 2001, Proc. Asia-Pac. Biochem. Eng. Conf., Springer, Tokyo, Japan, 1992, 613–616.
  • Electric potentiation, cooperativity, and synergism of magainin peptides in protein-free liposomes. VAZ-GOMES, A., DE WAAL, A., BERDEN, J. A., and WESTERHOFF, H. V., Biochemistry, 1993, 32, (20), 5365–5372.
  • Quantitative measurement of cationic fluxes, selectivity and membrane potential using liposomes multilabeled with fluorescent probes. VENEMA, K., GIBRAT, R., GROUZIS, J. P., and GRIGNON, C., Biochim. Biophys. Acta, 1993, 1146, (1), 87–96.
  • Therapeutic efficacy of the alpha -emitter astatine-211 bound on microspheres compared with yttrium-90 and phosphorus-32 colloids in a murine intraperitoneal tumor model. VERGOTE, I., LARSEN, R. H., DE VOS, L., NESLAND, J. M., BRULAND, O., BJOERGUM, J., AI,STAD, J., TROPE, C., and NUSTAD, K., Gynecol. Oncol., 1992, 47, (3), 366–372.
  • Distribution of intraperitoneally injected microspheres labeled with the alpha-emitter astatine (211At) compared with phosphorus (32P) and yttrium (90Y) colloids in mice. VERGOTE, I., LARSEN, R. H., DE VOS, L., WINDEREN, M., ELLINGSEN, T., BJ0F.RGUM, J., HOFF, P., AAS, M., TROPE, C., and NUSTAD, K., Gynecol. Oncol., 1992, 47, (3), 358–365.
  • Ionizing radiation target groups of band 3 inserted into egg lecithin liposomes as determined by Raman spectroscopy. VERMA, S. P., SINGHAL, A., and SONWALKAR, N., int. 7. Radial. Biol., 1993, 63, (3), 279–288.
  • Plasma dependent pH sensitivity of liposomes containing sulfatide. VIANI, P., CERVATO, G., GATTI, P., and CESTARO, B., Biochim. Biophys. Ada, 1993, 1147, (1), 73–80.
  • Time-resolved and equilibrium measurements of the effects of poly(ethylene glycol) on small unilamellar phospholipid vesicles. VIGUERA, A. R., MENCIA, M., and GONI, F. M., Biochemistry, 1993, 32, (14), 3708–3713.
  • Specific in vitro labeling of cells with a fluorine-19 probe encapsulated in antibody-targeted liposomes: a fluorine-19 NMR spectroscopy study. VION, D. J., MACHY, P., CONFORT, G. S., LESERMAN, L., and COZZONE, P. J., Magn. Reson. med., 1993, 29, (2), 252–255.
  • Formulation and evaluation of vinylpyrrolidone/vinyl acetate copolymer microspheres with griseofulvin. VOJNOVIC, D., RUBESSA, F., BOGATAJ, M., and MRHAR, A., J. Microencapsulation, 1993, 10, (1), 89–99.
  • Conversion of liposomal 5-fluoro-2'-deoxyuridine and its dipalmitoyl derivative to bile acid conjugates of alpha-fluoro-beta-aniline and their excretion into rat bile. WAALKES, M. VAN B., KUIPERS, F., HAVINGA, R., and SCHERPH0F, G. L., Biochim. Biophys. Acta, 1993, 1176, (1-2), 43–50.
  • Na-nuclear magnetic resonance study of inophore-mediated cation exchange between two populations of liposomes. WALDECK, A. R., and KUCHEL, P. W Biophys. y., 1993, 64, (5), 1445–1455.
  • Divalent cation-induced lipid mixing between phosphatidylserine liposomes studied by stopped-flow fluorescence measurements: effects of temperature, comparison of barium and calcium, and perturbation by DPX. WALTER, A., and SIEGEL, D. P., Biochemistry, 1993, 32, (13), 3271–3281.
  • Citric acid as a plasticizer for spray-dried microcapsules. WAN, L. S. C., HENG, P. W. S., and CHIA, C. G. H., J. Microencapsulation, 1993, 10, (1), 11–23.
  • Potassium-conducting ion channel of the chloroplast inner envelope: functional reconstitution into liposomes. WANG, X., BERKOWITZ, G. A., and PETERS, J. S., Proc. Natl. Acad. Sci. USA, 1993, 90, (11), 4981–4985.
  • Liposome production: the sizing-up technology starting from mixed micelles and the scaling-up procedure for the topical glucocorticoid betamethasone dipropionate and betamethasone, WEDER, H. G., Liposome Dermatics, Griesbach Conf., Springer, Berlin, Germany, 1992, 101–109.
  • Topical delivery of liposomally encapsulated interferon evaluated by in vitro diffusion studies and in a cutaneous herpes guinea pig model. WEINER, N., EGBARIA, K., and RAMACHANDRAN, C., Liposome Dermatics, Griesbach Conf., Springer, Berlin, Germany, 1992, 242–250.
  • Carboxyacyl derivatives of cardiolipin as four-tailed hydrophobic anchors for covalent hydrophilic protein coupling to liposomes. WEISSIG, V., NIEDERMANN, G., and LASCH, J., Proc. Int. Symp. Controlled Release Bioact. Mater., 19th, Controlled Release Soc., Deerfield, Ill, 1992, 343–344.
  • Inhibition of cell adhesion by microspheres coated with recombinant soluble intercellular adhesion molecule-1. WELDER, C. A., LEE, D. H. S., and TAKEI, F., y. Immunol., 1993, 150, (6), 2203–2210.
  • Microencapsulated indomethacin tablets. WEN, R., and Lu, B., Zhongguo Yiyao Gongye Zazhi, 1992, 23, (12), 543–546.
  • Microcapsules for cell entrapment by template polymerization of a synthetic hydrogel coating around calcium alginate gel: preliminary development. WEN, S., and STEVENSON, W. T. K., J. Mater. Sci.: Mater. Med., 1993, 4, (1), 23–31.
  • Liposome dermatics: chemical aspects of the skin lipid approach. WERTZ, P. W., Liposome Dermatics, Griesbach Conf., Springer, Berlin, Germany, 1992, 38–43.
  • Vitamin D is a membrane antioxidant. Ability to inhibit iron-dependent lipid peroxidation in liposomes compared to cholesterol, ergosterol and tamoxifen and relevance to anticancer action. WISEMAN, H., BESS Lett., 1993, 326, (1-3), 285–288.
  • Distribution of liposome-encapsulated ingredients in human skin ex vivo. WOHLGRAB, W., LASCH, J., LAUB. R., TAUBE, C. M., and WELLNER, K., Liposome Dermatics, Griesbach Conf., Springer, Berlin, Germany, 1992, 215–225.
  • Gallium-67-labeled liposomes with prolonged circulation: preparation and potential as nuclear imaging agents. W000L,E, M. C., Nucl. Med. Biol., 1993, 20, (2), 149–155.
  • Preparation of liposomes with hydrocortisone and hydrocortisone esters. WOYCZIKOWSKI, B., Szut.c, J., and JANIcmt, S., Farm. Pol., 1992, 48, (9-10), 609–612.
  • Distribution of harringtonine in positively and negatively charged liposomes in rat tissues. Wu, H., WENG, G., ZHOU, X., and CHENG, D., Zhongguo Yaoli Xuebao, 1993, 14, (2), 176–178.
  • Preparation and release behavior of ethyl cellulose microcapsules containing theophylline dispersed in cellulose triacetate matrixes. Wu, J. C., JEAN, W. J., and CHEN, H., y. Chin. Chem. Soc. (Taipei), 1993, 40, (1), 23–28.
  • Transmembrane 19F NMR chemical shift difference of fluorinated solutes in liposomes, erythrocytes and erythrocyte ghosts. Xu, A. S., WALDECK, A. R., and KUCHEL, P. W., NMR Biomed., 1993, 6, (2), 136–143.
  • A novel hollow-glass microsphere sensor for monitoring high hydrostatic pressure. XL, M. G., and DAKIN, J. P., Proc. SPIE Int. Soc. Opt. Eng., 1993, 1795 (Fiber Optic and Laser Sensors X), 2–7.
  • Thermal characteristics of poly(n-lactic acid) microspheres containing neurotensin analog. YAMAKAWA, I., ASHIZAWA, K., TsuDA, T., WATANABE, S., HAYASHI, M., and AWAZU, S., Chem. Pharm. Bull., 1992, 40, (10), 2870–2872.
  • Dynamic MR imaging of hepatoma treated by transcatheter arterial embolization therapy. Assessment of treatment effect. YAMASHITA, Y., YOSHIMATSU, S., SUMI, M., HARADA, M., and TAKAHASHI, M., Acta Radial., 1993, 34, (3), 303–308.
  • Effects of glycophorin and ganglioside GM3 on the blood circulation and tissue distribution of liposomes in rats. YAMAUCHI, H., KIKUCHI, H., YACHI, K., SAWADA, M., TOMIKAWA, M., and HIROTA, S., Int. 5. Pharm., 1993, 90, (1), 73–79.
  • Yttrium-90 glass microspheres injected via the portal vein. An experimental study. YAN, Z. P., LIZ, G., ZHAO, H. Y., and DONG, Y. H., Acta Radiol., 1993, 34, (4), 395–398.
  • Liposome-encapsulated enzymes for DNA repair. YAROSH, D. B., Liposome Dermatics, Griesbach Conf., Springer, Berlin, Germany, 1992, 258–269.
  • Antitumor effects of liposome-entrapped carboplatin after intraperitoneal administration in rats. YASUI, T., MIZUNO, I., IumN(), T., YAMAMOTO, T., and YOTSUYANAGI, T., Nagoya Med. 5., 1992, 37, (2–3), 71–79.
  • A novel method for blood group typing with the aid of monoclonal antibody-immobilized dyed microspheres. YAZAWA, S., OHKAWARA, H., NAKAJIMA, T., 1-10.s0mi, O., TAKEYA, A., and FURUKAWA, K., Nippon Hoigaku Zasshi, 1992, 46, (6), 440–444.
  • Effects of short chain n-alkanols on stratum corneum lipid liposomes (SCLL): a fluorescence probe study. YONETO, K., Kim, Y. H., HIGUCHI, W. I., and HERRON, J. N., Proc. Int. Symp. Controlled Release Bioact. Mater., 19th, Controlled Release Soc., Deerfield, Ill, 1992, 472–473.
  • Excitation energy transfer in liposomes. Fluorescence quenching of coumarin dye by retinal. YONEZAWA, Y., IWABUCHI, H., SATO, T., TERASH1MA, S., and KATOH, S., Nippon Shashin Gakkaishi, 1992, 55, (5), 325–336.
  • Synthesis of galactose derivatives that render lectin-induced agglutinating ability to liposomes. YOSHIOKA, H., OHMURA, T., HASEGAWA, M., HIROTA, S., MAKIN°, M., and KAMIYA, M., 5. Pharm. Sci., 1993, 82, (3), 273–275.
  • Preparation and extraction properties of microcapsules containing tri-n-octyl amine as core material. YOSHIZAWA, H., UEMURA, Y., KAWANO, Y., and HATATE, Y., j. Chem. Eng. jpn., 1993, 26, (2), 198–204.
  • H + countertransport and electrogenicity of the sarcoplasmic reticulum Ca2+ pump in reconstituted proteoliposomes. Yu, X., CARR01.1 „ S., REGAL:I), J. L., and INES I, G., Biophys. 7., 1993, 64, (4), 1232–1242.
  • The effect of liposomes varying in composition of ADP-induced platelet aggregation. ZAKREVSKY, V. I., RUDKO, I. A., and KuBATTEv, A. A., Byull. Eksp. Biol. Med., 1992, 114, (11), 646–466.
  • Antineoplastic activity in vitro of free and liposomal alkylphosphocholines. ZEISIG, R., JUNGMANN, S., ARNDT, D., SCHUETT, A., and NISSEN, E., Anticancer Drugs, 1993,4, (1), 57–64.
  • Clinical regulatory aspects of topical liposomal drugs with special consideration of safety aspects. ZESCH, A., Liposomes Dermatics, Griesbach Conf., Springer, Berlin, Germany, 1992, 288–296.
  • Experimental therapy of alprenolol-targeted liposome. ZHANG, L., CHEN, Y., SONG, L., DONG, S., TANG, J., Su, J., and TANG, C., Beijing Yike Daxue Xuebao, 1992, 24, (5), 360–362.
  • The physical properties, pharmacology, and antifertility action of crystal trichosanthin protein liposome. ZHANG, X. C., Li, W., and Wu, Q., Yaoxue Xuebao, 1993, 28, (4), 290–295.
  • Tension-stabilized pores in giant vesicles: determination of pore size and pore line tension. ZHELEV, D. V., and NEEDHAM, D., Biochim. Biophys. Acta, 1993, 1147, (1), 89–104.
  • Liposome-encapsulated hemoglobin processing methods. ZHENG, S., ZHENG, Y., BEISSINGER, R. L., and FRESCO, R., Biomater., Artif. Cells. Immobilization Biotechnol., 1992, 20, (2-4), 355–364.
  • Preparation and evaluation in vitro and in vivo of copoly (lactic/glycolic) acid microspheres containing norethistoerone. ZHOU, Z., ZHOU, M., WANG, S., LIZ, F., and SHAN, W Biomater. Artif. Cells Immobilization Biotechnol., 1993, 21, (1), 71–84.
  • Preparation and in vitro and in vivo study of ethyl cellulose microspheres containing 5-fluorouracil. ZINUTTI, C., KED1EREWICZ, F., PICARD, L., BARBERI, M., MERLIN, J. L., HOFFMAN, M., and MAINCENT, P., Congr. Int. Technol. Pharm., 6th, Assoc. Pharm. Galenique Ind., Chatenay Malabry, Fr., 1992, 262–269.
  • Organ distribution and tumor uptake of annamycin, a new anthracycline derivative with high affinity for lipid membranes, entrapped in multilamellar vesicles. Z0u, Y., PRIEBE, W., LING, Y. H., and PEREZ-SOLER, R., Cancer Chemother. Pharmacol., 1993, 32, (3), 190–196.
  • Enhanced therapeutic effect against liver W256 carcinosarcoma with temperature-sensitive liposomal adriamycin administered into the hepatic artery. Zou, Y., YAMAGISHI, M., HORIKOSHI, I., UENO, M., Gu, X., and PEREZ-SOLER, R., Cancer Res., 1993, 53, (13), 3046–3051.
  • Organ distribution and antitumor activity of free and liposomal doxorubicin injected into the hepatic artery. Zou, Y., HORIKOSHI, I., KASAGI, T., Gu, X., and PEREZ-SOLER, R., Cancer Chemother. Pharmacol., 1993, 31, (4), 313–318.
  • Effect of glycosaminoglycans and PEG on fusion of Sendai virus with phosphatidylserine vesicles. ZSCHORNIG, O., ARNOLD, K., and OHKI, S., Biochim, Biophys. Acta, 1993, 1148, (1), 1–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.